ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000136.1|Rifamycin_1 # 145 # 720 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0000136.1|Rifamycin_1 	145	720	+	Loose	850	26.1794	OprM	33.33	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGTTGTTGGTGCCGAACAGGGACCGGAAGGCCGGCGTCGTCCAGCCGAGCTCGATCGCGGAGAGCTTCCGCACCAGCTCGGCCACCGTCGTTACCCAGTACACCGGCCTCTCCGTGTCCCAGCTGTCCCAGCTGCGCCGCGCTCTCGGCACCAGTGCCAAGTACCGGGTCGCGAAGAACACCCTGGTCAAGCGGGCGGCCGAGGACGCCGGCATCCAGGGTCTCGAGGACCTGTTCGTCGGCGCGACCGCCATCGCCTTCGTCGAGGGTGAAGCAGTCGACGCCGCCAAGGCGATTCGCGACTTCGCGAAGGACAACAACGCGCTTGTGATCAAGGGCGGCTACATGGACGGCCGAGCGCTGTCCGTGGACGAGATCAACCGGATTGCCGATCTCGACAGCCGTGAGGTCCTGCTCGCCAAGGCGGCGGGCGCGTTCAAGGCGAAGCTTTCCCAGGCCGCCGCGCTGTTCCAGGCGCCGGCGTCCCAGGTCGCCCGCCTGGCTGCCGCGCTGGAGGAGAAGCAGCGCAACGCCGCCGGTACCGAAGCAGCCGAAGCACCCGCCGAGAGCTGA	MPLLVPNRDRKAGVVQPSSIAESFRTSSATVVTQYTGLSVSQLSQLRRALGTSAKYRVAKNTLVKRAAEDAGIQGLEDLFVGATAIAFVEGEAVDAAKAIRDFAKDNNALVIKGGYMDGRALSVDEINRIADLDSREVLLAKAAGAFKAKLSQAAALFQAPASQVARLAAALEEKQRNAAGTEAAEAPAES	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	39.38	gnl|BL_ORD_ID|2355|hsp_num:0	1305			516	768	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; thiamphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; norfloxacin; ofloxacin; panipenem; ticarcillin; trimethoprim-sulfamethoxazole; gentamicin
BGC0000136.1|Rifamycin_2 # 770 # 1153 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.682	BGC0000136.1|Rifamycin_2 	770	1153	+	Loose	2000	25.0238	Staphylococcus aureus mupA conferring resistance to mupirocin	26.98	3000521	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGGCGAAGCTGAGCACCGCCGAGCTGATCGACGCCTTCAAGGAGCTGACCCTCCTCGAGCTGTCCGAGTTCGTGAAGGAGTTCGAAGAGGTCTTCGACGTGACCGCCGCCGCGCCGGTCGCCGTTGCCGCCGGCCCGGCCGCCGCCGCTGCCGCCCCGGTCGAGGAGCAGGACGAGTTCGACGTCGTCCTCGAGGGCGCCGGCGACAAGAAGATCCAGGTCATCAAGGTCGTCCGCGAGGTCGTCTCGGGCCTGGGCCTGAAGGAGGCCAAGGAGCTGGTCGAGGCCGCTCCCAAGGCCCTCCTGGAGAAGGTCGACAAGGAGGCCGCCGAGGCCGCCAAGGAGAAGCTCGAGGCCGCGGGCGCCAAGATTTCCATCAAGTGA	MAKLSTAELIDAFKELTLLELSEFVKEFEEVFDVTAAAPVAVAAGPAAAAAAPVEEQDEFDVVLEGAGDKKIQVIKVVREVVSGLGLKEAKELVEAAPKALLEKVDKEAAEAAKEKLEAAGAKISIK	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	12.40	gnl|BL_ORD_ID|4699|hsp_num:0	2270			789	975	mupirocin
BGC0000136.1|Rifamycin_3 # 1559 # 2731 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=4bp;gc_cont=0.682	BGC0000136.1|Rifamycin_3 	1559	2731	+	Loose	500	145.976	RanA	32.91	3005091	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGTGCCGAGGTGGTCATCGAAGGTCTGACGAAGTCCTTCGGTAAGCAGGCCATCTGGCGGGACGTCACGTTGACGCTCCCCCCGGGCGAAGTGTCGGCCATGCTCGGCCCGTCGGGGACCGGCAAGTCGGTCTTCCTGAAGTCGATGATCGGGCTGCTCAAGCCCGACCGCGGCCGCTGCATGATCAACGGGGTGGACATCGTCACCTGCTCCGAGCACAAGCTGTACGAGATCCGGAAGCTCTTCGGTGTCCTCTTCCAGGACGGCGCGCTGTTCGGCTCGATGAACCTCTACGACAACGTCGCCTTCCCGCTGCGTGAGCACACGAAGAAGTCCGAGACGGAAATCCGCCGGATCGTGCTCGAGAAGCTCGACATGACCGGTCTGAACGGCGCCGACAAGAAGCTGCCGGGCGAGATCTCCGGCGGGATGCGCAAGCGCGCCGGCCTGGCCCGCGCCCTGGTGCTCGACCCGGAGATCATCCTGGTCGACGAGCCGGACTCGGGCCTCGACCCGGTCCGCACCACCTACATCTCGCAGCTGTTCCTCGACGTCAACGCGCAGATCGACGCGACGTTCCTGATCGTCACCCACAACATCAACCTGGCCCGCACGGTGCCGGACAACCTGGGCATGCTCTTCCGCAAGGAACTGGTCATGTTCGGCCCGCGCGAGGTGCTGCTGACCAGCGAAGAGCCGGTCGTCAAGCAGTTCCTCAACGGCAAGATGCAGGGCCCGATCGGCATGTCCGAGGAGAAGGACAGCGCCCAGATGGCCGCCGAGCAGGCGATGTTCGAAGCCGGCCACCACGCGGGCGGGGTCGAGGACGTCTCCGGCGTGCCGCCGCAGATGCAGCCGACGCCGGGCGTGCCCACCCGGATGGGTGCCGTCCGCCGCAAGGACCGGGTCATGGAGATCATGCACCGGCTGCCGCCGGCCGCGCAGGAAAGCATCATCGAGTCGCTGAGCCCCGAGGAGCAGCGCCACTACGGTGTGCGGCCGCACCGCGGGCAGCCGCAGCAGGTCGGCGCCCGCCCGCAGGGTGACGGCGTCCCGAACCAGCACCACGGGCAGCTGCCCGCCGACCAGGTGGCGCGGATCCCCGGCGGCCAGCCGCCGAGAACCGGCACGCACCGAATGCCACCGAACAACGGGCCAGGTGGCCGGTGA	MGAEVVIEGLTKSFGKQAIWRDVTLTLPPGEVSAMLGPSGTGKSVFLKSMIGLLKPDRGRCMINGVDIVTCSEHKLYEIRKLFGVLFQDGALFGSMNLYDNVAFPLREHTKKSETEIRRIVLEKLDMTGLNGADKKLPGEISGGMRKRAGLARALVLDPEIILVDEPDSGLDPVRTTYISQLFLDVNAQIDATFLIVTHNINLARTVPDNLGMLFRKELVMFGPREVLLTSEEPVVKQFLNGKMQGPIGMSEEKDSAQMAAEQAMFEAGHHAGGVEDVSGVPPQMQPTPGVPTRMGAVRRKDRVMEIMHRLPPAAQESIIESLSPEEQRHYGVRPHRGQPQQVGARPQGDGVPNQHHGQLPADQVARIPGGQPPRTGTHRMPPNNGPGGR	MIEVKDLRKSFNDVEVLKGITTTFETGKINLVIGQSGSGKTVFLKCLLNVFDPSSGDILFDGRNLSIMGRTEKQEIRSEIGTVFQGSALFDSMTVEENISFPLDMFTNLTYTEKRKRVKEVIGRVHLENANTKFPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTAIVIDELIKEITEEYNTTTIINTHDMNSVLTIGEKIVYLRKGVKEWEGNKDLIIKAENEHLIDFVYSSALFKQVRETMLRNNQTNL	151.16	gnl|BL_ORD_ID|2808|hsp_num:0	3825			9	711	
BGC0000136.1|Rifamycin_4 # 2728 # 3522 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.691	BGC0000136.1|Rifamycin_4 	2728	3522	+	Loose	450	82.0333	RanB	28.57	3005090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAGCTCTCCCGCAACACAGGCGAAGATCCCCGGGATCGGCATGCTCCGCGAGACCGGGAACCTGTTCGCTCTCGGCCTGGACATCGTCCGCGGCCTGTTCCAGCGCCCGTTCCAGCTGCGGGAGTTCATCCAGCAGTCGTGGTTCATCGCGAGCGTGACGATCCTGCCGACGGCCCTGGTGGCCATCCCGTTCGGTGCCGTCATCTCGCTGCAGTTCGGGTCGCTCGCCCGCCAGCTGGGCGCGCAGTCCTACACCGGCGCGGGCTCCGTGCTCGCCACCGTGCAGCAGGCCAGTCCGCTGGTCACCGCGCTGCTGGTGGCGGGTGCGGGCGGCTCCGCCGTCTGCGCCGACATCGGCGCCCGGACCATCCGCGAAGAGATCGCCGCGATGGAGGTGCTCGGCGTCTCCGCGGTGCAGCGGCTGATCGTGCCGCGCACCCTCGCGATGATGCTGGTCGCGCTCCTGCTCAACGGCATGGTCAGCGTCATCGGCGTGCTCGGCGGCTACTTCTTCAACGTCGTGCTGCAGGGCGGGACGCCGGGTGCGTACCTGGCGAGCTTCTCCGCCCTCGCGCAGCTGCCCGACCTCTGGGTCGGCGAGCTCAAGGCGCTGATCTTCGGGTTCATCGCCGCCGTCGTCGCGTCCTACCGGGGCCTGAACCCCTCCGGCGGCCCGAAGGGCGTCGGGGACGCGGTGAACCAGTCGGTGGTCATCACGTTCCTGCTGCTGTTCGTCGTGAACTTCGTGATCACCCTGATCTACCTGCAGATCGTGCCCGGAAAGCTGGACTAG	MSSPATQAKIPGIGMLRETGNLFALGLDIVRGLFQRPFQLREFIQQSWFIASVTILPTALVAIPFGAVISLQFGSLARQLGAQSYTGAGSVLATVQQASPLVTALLVAGAGGSAVCADIGARTIREEIAAMEVLGVSAVQRLIVPRTLAMMLVALLLNGMVSVIGVLGGYFFNVVLQGGTPGAYLASFSALAQLPDLWVGELKALIFGFIAAVVASYRGLNPSGGPKGVGDAVNQSVVITFLLLFVVNFVITLIYLQIVPGKLD	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	104.35	gnl|BL_ORD_ID|2807|hsp_num:0	3824			240	759	
BGC0000136.1|Rifamycin_5 # 3527 # 4363 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.658	BGC0000136.1|Rifamycin_5 	3527	4363	+	Loose	450	77.411	RanB	31.16	3005090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACGTTCCTCCAGGGCGCGAAACGCGTCGTCAACCGACCCCTCCAGACACTGGACACCTTGGGTGACCAGATGTCGTTCTACGGCCGCGCGCTGCTGTGGACGCCGCGGACGCTGCGCCGCTACACCAAAGAGGTGCTCCGGCTGCTGGCCGAGGTGAGCTTCGGGTCCGGCTCGCTGGCGGTCATCGGCGGCACGGTGGGCGTGATGGTCGGCCTGACGCTGTTCACCGGTGTCCTCGTCGGCCTCCAGGGCTATTCGGCGCTGAACTCGATCGGGACGTCGGCCTTCACCGGCTTCCTGACCGCGTTCTTCAACACGCGCGAGATCGCCCCGCTGGTCGCCGGGCTCGCCCTGAGCGCCACCGTCGGCGCCGGGTTCACCGCGCAGCTGGGCGCCATGCGGATCTCGGAGGAGATCGACGCACTGGAAGTCATGGGTGTGCCGAGCCTGCCGTACCTGGTGACGACGCGGATCATCGCCGGGTTCGTCGCGGTCATCCCGCTCTACATCATCGGCCTGCTGAGCTCGTACCTCGCGTCGAGACTGGTCGTGATCTACATCTACCACCAGTCGGCCGGTACCTACGACCACTACTTCGACCTGTTCCTGCCCCCGCAGGACGTGCTGTATTCGTTCATCAAGGTGCTGCTGTTCAGCGTCCTGATCATCCTGTCGCACTGCTACTTCGGGTACCGGGCGACCGGTGGCCCGGCCGGGGTCGGCGTCGCGGTCGGCAAGGCCGTGCGGCTGTCCATCGTCACGGTGTCGATCATGAACTTCTTCATCGGGTTCGCCATCTGGGGAACCGACGTCACGGTAAGGATCGCGGGATGA	MTFLQGAKRVVNRPLQTLDTLGDQMSFYGRALLWTPRTLRRYTKEVLRLLAEVSFGSGSLAVIGGTVGVMVGLTLFTGVLVGLQGYSALNSIGTSAFTGFLTAFFNTREIAPLVAGLALSATVGAGFTAQLGAMRISEEIDALEVMGVPSLPYLVTTRIIAGFVAVIPLYIIGLLSSYLASRLVVIYIYHQSAGTYDHYFDLFLPPQDVLYSFIKVLLFSVLIILSHCYFGYRATGGPAGVGVAVGKAVRLSIVTVSIMNFFIGFAIWGTDVTVRIAG	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	109.88	gnl|BL_ORD_ID|2807|hsp_num:0	3824			144	726	
BGC0000136.1|Rifamycin_6 # 4360 # 5685 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.689	BGC0000136.1|Rifamycin_6 	4360	5685	+	Loose	550	25.409	vgbB	40.0	3001308	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin B antibiotic	antibiotic inactivation	streptogramin vgb lyase	ATGAGGACGCTCCGACGCAGGCTGCTCGGCCTGCTGCTCATCGCCGTGATGGTCGGCGGGGTGGCGCTGTCCATCGCGCTCTACGACAAGGCGTTCACCCCGGTCGTCACGGTCAGGCTGCAGGCCGACAAGATCGGCAACCAGCTGATCAAGCAGTCCGACGTCAAGGTGCGCGGCCTGATCGTCGGCTCGGTGCAGGACATCGTCGCCACCGACCACGGCGCCGAGCTGACCCTGGCGCTCCAGCCGGAGTCCGCGAAGCTCATCCCGGAGAACGTCTCGGCGCGGTTCCTGCCCAAGACGCTCTTCGGCGAGCGGTTCGTCTCGCTGGAGATCCCGAAGGACCCGTCGGCCAAGACGATCGCAGACGGCGACGTCATCCCGCAGGACCGCACGTCGAGCGCGATCGAGCTGGACCAGGCCTTCGAGCACCTGATGCCGGTGCTGCAGGCGGTGCAGCCGCAGAAGCTGTCGGCGACGCTCACCGCGATCTCGACCGCGCTGCAGGGCCGCGGCGACCAGCTCGGCGACACGCTCTCGCAGCTGGGCACCTACATCGGCGAGCTGAACCCGCACGAGCCGGAGCTGCAGCACAACCTCAAGGCGCTCGCGGAGTTCTCCGACCACCTCAAGGACGCGGCCCCGGACCTGGTGCAGAGCCTGGACAACCTGAGCACGACAACCCGCACCGTGGTCGACGAGCGGCAGAACCTGTCGAACCTCTACGGCAGCCTGACCCAGGCCTCGGTGGACCTGCAGACGTTCCTGCAGAACAACAAGGACAACATCATCTCCCTCGTCGACACCGCCCGGCCGACGGCCGAACTGCTGGCGAAGTACGCGCCGGAGTACCCCTGCGTGATCTCCCAGATGGCCAAGAACGTGCCGCTGATCGACCAGGCGCTCGGCAAGGGCACCAACCAGCCCGGCCTGCACGCGACCATCGAGATCATCGTCCCGCGCGCGCCGTACCAGGCGGGCAAGGAAGAGCCGCGGTTCGACGACAAGCGCGGCCCGCGCTGCTACGACATCAAGGACATCCCGAAGCCGTTCCCGTCCGAGCCGCCGGACGGCGCGTTCAAGGACGGCACGCTGCACCAGGCCGCGCCGAAGAGCGTCGGCGAGGGCCTCAACCCGGCCAAGTTCAAGGCGGACTCGGCCGGCAACGGCGGCAGCGGTGGTGATCTGGCGTACTCGACGGCGGAGCAGGGCTTCCTGGCCGACCTGCTCGGCCCGCAGCTGGGCATGAGCGCCGCGGACGTCCCGGGCTGGAGCTCGCTGCTCGTCGGCCCGCTGTACCGGGGTGCGGAGGTGACGGTCAAGTGA	MRTLRRRLLGLLLIAVMVGGVALSIALYDKAFTPVVTVRLQADKIGNQLIKQSDVKVRGLIVGSVQDIVATDHGAELTLALQPESAKLIPENVSARFLPKTLFGERFVSLEIPKDPSAKTIADGDVIPQDRTSSAIELDQAFEHLMPVLQAVQPQKLSATLTAISTALQGRGDQLGDTLSQLGTYIGELNPHEPELQHNLKALAEFSDHLKDAAPDLVQSLDNLSTTTRTVVDERQNLSNLYGSLTQASVDLQTFLQNNKDNIISLVDTARPTAELLAKYAPEYPCVISQMAKNVPLIDQALGKGTNQPGLHATIEIIVPRAPYQAGKEEPRFDDKRGPRCYDIKDIPKPFPSEPPDGAFKDGTLHQAAPKSVGEGLNPAKFKADSAGNGGSGGDLAYSTAEQGFLADLLGPQLGMSAADVPGWSSLLVGPLYRGAEVTVK	MNFYLEEFNLSIPDSGPYGITSSEDGKVWFTQHKANKISSLDQSGRIKEFEVPTPDAKVMCLIVSSLGDIWFTENGANKIGKLSKKGGFTEYPLPQPDSGPYGITEGLNGDIWFTQLNGDRIGKLTADGTIYEYDLPNKGSYPAFITLGSDNALWFTENQNNSIGRITNTGKLEEYPLPTNAAAPVGITSGNDGALWFVEIMGNKIGRITTTGEISEYDIPTPNARPHAITAGKNSEIWFTEWGANQIGRITNDKTIQEYQLQTENAEPHGITFGKDGSVWFALKCKIGKLNLNE	149.49	gnl|BL_ORD_ID|4679|hsp_num:0	1144			126	231	pristinamycin IA; quinupristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3
BGC0000136.1|Rifamycin_7 # 5682 # 6710 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.671	BGC0000136.1|Rifamycin_7 	5682	6710	+	Loose	1300	25.7942	mecB	45.0	3003440	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGAGGGGCCTGCTCGCGCCGCTGATCAAGCTCGGCATCTTCGTGGTCGTCACCGTGCTGTTCACGACGATCCTCGGGATCAGCATCGCCAACATCAACACCACCAGCACCAACGCCTACAACGCGCGCTTCACCGACGCGACGCTGCTGCTGCCCAACGACGACGTCCGCATCGCCGGCGTCCGGGTCGGGCAGGTCAAGGACGTGCACATCGTCGACAAGCGCCAAGCCGAGGTCGAGTTCGAGGTCGACGCCGGCCGGACGCTGCCGGCCGGGGTGACCGCGCAGATCAAGTTCCGCAACCTGGTCGGGCAGCGGTACGTCTCGCTCGGCGAGGGCGACGACAGCGCCGGCAAGACGCTGCCGCCCGGCGGCACCATCCCGCTGGAGCGGACCACGCCGGCGCTGGACCTGACCGAGCTGTTCAACGGCTTCAAGCCGCTGTTCACCGCGCTCAACCCCGAGGACGTCAACAAGCTGTCCTACGAGGTCATCCAGGTCCTGCAGGGCGAGGGCGGCACCGTGGAAAGCCTGCTTTCGCACACGGCGTCGCTGGCCACCACGATCGCCGACAAGGACCAGGTGATCGGCGAGGTCATCGACAACCTCAACTCGGTGCTCGACACGGTCAACGCGCACACGCCGCAGCTCAACGACCTGATCGTGAAGCTGCAGCAGCTGGTGTCCGGGCTGGCCGCCGACCGCAAGCCGATCGGCGACGCGATCGAGAGCCTCGGCAACCTGGCGCAGACGACGTCCGGGCTGCTCGGCGAGGTCCGCGAGCCGCTGAAGAACGACATCGACGCGCTCGGGAACCTGACGAGCGCGCTCAACAAGAACGAGCCGGAGCTGGAGCACTTCATCCAGTTCCTGCCGACCAAGGTGAGCACGCTGACCCGCACCGCGGACTACGGCTCCTGGTTCAACTTCTACGCCTGTGAGTTCTCCGGGAGCGTGAGCTTGCCGCCACTGATCAACGACGTCGCCCTGCCCCTGATCCCGGCGAACCGGGCGAGGTGCCAGGGATGA	MRGLLAPLIKLGIFVVVTVLFTTILGISIANINTTSTNAYNARFTDATLLLPNDDVRIAGVRVGQVKDVHIVDKRQAEVEFEVDAGRTLPAGVTAQIKFRNLVGQRYVSLGEGDDSAGKTLPPGGTIPLERTTPALDLTELFNGFKPLFTALNPEDVNKLSYEVIQVLQGEGGTVESLLSHTASLATTIADKDQVIGEVIDNLNSVLDTVNAHTPQLNDLIVKLQQLVSGLAADRKPIGDAIESLGNLAQTTSGLLGEVREPLKNDIDALGNLTSALNKNEPELEHFIQFLPTKVSTLTRTADYGSWFNFYACEFSGSVSLPPLINDVALPLIPANRARCQG	MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRYKRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITKKWLLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKKNKKNISKLLSISESTLNKKLKQTWVKEGVFLPLKSYIELDDELKLGIQKYHLTVNQTKGRVYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVITSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLALVSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTIDASTSYNIVTKGWQRNSSWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFIKGMKALDIGRNIPSDYYFQKGQIANPESLKNNFKNEILLADSGYGQGEILISPVQILSIYSSLINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFAGKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENKGMSSYNARKFAEIMDELYENGTKKYEIDR	50.74	gnl|BL_ORD_ID|1459|hsp_num:0	1595			1899	1959	methicillin
BGC0000136.1|Rifamycin_8 # 6707 # 7693 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.666	BGC0000136.1|Rifamycin_8 	6707	7693	+	Loose	750	27.335	smeD	36.36	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGTCCTTCCAGAAGCGCAACCCCGTGCCGATCGCGCTGGTCGGGATCGTCGTGCTGGCGCTCGCCTTCACCGCCGCGCTCAACTCCGACGACCTGCCGGTGATCGGCGGGGGCACCACCTACAGCGCCGAGTTCAGCGAGGCTTCCGGGCTGCAGAAGGACAACGACGTCCGGATCGCCGGCGTCAAGGTCGGCAAGGTCAGCGACATCGCGCTCGACGGCGCGTCGGTGAAGGTGTCTTTCAAGGTCAAGGACGCCTGGCTGGGCGACCGGACCAGTGCCGCGATCAAGATCAAGACGTTGCTCGGGCAGAAGTACCTGTCGCTGGACCCGCAGGGTGAGACCGCGCTGAACCCGGGCACCGGCATCCCGCGCGACCGCACGATGGCACCCTACGACGTGCTCGACGCCTTCCGCGGGCTGTCCCAGACCGTCGACAACATCGACACCAAGCAGCTGGCGCAGAGCTTCGACACGATCTCGCAGACCTTCGCCAACACGCCGCAGGACGTGAAGGGCGCGCTGTCGGGGCTGTCGAAGCTGTCGGACACGATCGCCTCGCGCGACCAGCAGCTGTCGAACCTGCTGGCCAACACCCGCCAGGTGTCGCAGACGCTGGTCGACCGCGACGCCGAGGTGCAGAAGCTGCTCGACGACGGCAACGACCTGCTCGCCGAGCTGGCCAAGCGCGAGGACGCGATCACCGCGCTGCTGGACGGCTCCCGCGAGCTGGCCACCCAGCTGCAGGGCCTGATCGACGACAACGGAAAGCAGCTCGACCCGGTGCTGACCCAGCTCGACCAGCTGACGTCGATGCTGCAGCGCAACCAGGACTCCCTCGCCGAGGGGCTCAAGAAGTTCGCGCCGTTCATCCGCGTCTTCACCAACACCATCGGCAACGGCCGCTGGTTCGACAACTACATCTGCGGCCTGCTGCTGCCGTCGTTCGGCCCGATCAACGAAGAGGGGTGCTACACGAAATGA	MKSFQKRNPVPIALVGIVVLALAFTAALNSDDLPVIGGGTTYSAEFSEASGLQKDNDVRIAGVKVGKVSDIALDGASVKVSFKVKDAWLGDRTSAAIKIKTLLGQKYLSLDPQGETALNPGTGIPRDRTMAPYDVLDAFRGLSQTVDNIDTKQLAQSFDTISQTFANTPQDVKGALSGLSKLSDTIASRDQQLSNLLANTRQVSQTLVDRDAEVQKLLDDGNDLLAELAKREDAITALLDGSRELATQLQGLIDDNGKQLDPVLTQLDQLTSMLQRNQDSLAEGLKKFAPFIRVFTNTIGNGRWFDNYICGLLLPSFGPINEEGCYTK	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	83.25	gnl|BL_ORD_ID|255|hsp_num:0	284			870	1029	tetracycline; chloramphenicol
BGC0000136.1|Rifamycin_9 # 7690 # 8874 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.695	BGC0000136.1|Rifamycin_9 	7690	8874	+	Loose	200	27.335	vanH gene in vanO cluster	31.58	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAGTGACACCCGCTTCGGACTGGCCCTGACCCGGGGCTTCACCATCGCGATCGTCCTCGCGCTCGTCGTCGCCGGCGGGATCTGGTGGACCCTCAAGGACGCCGGCCGCAACCACCTGACCGCGTACTTCGCCGGCGCCGTCGGCCTGTACGAGGGCAACAGCGTGCGGATGCTCGGCGTCGACATGGGCACGGTCACCAAGATCACCCCGATGGGCAACCAGGTGAAGGTCGACTTCGAGTACGACCGCTCGGTCGCCGTCCCGGCGGACGCGAAGGCGCTCATCGTGGCGCCGTCGCTGGTGTCCGACCGCTACGTCCAGCTGGCCCCGGCCTACACCGGCGGCCCGCGGATCTCCGACGGCGCGGTCATCGGCCTCGACCGCACCGAGGTGCCGCTGGAGGTCGACCAGCTGGCGGCCAGCCTGGCCCGGGTCAGCGAGACCCTCGGCCCGAACGGCGCCAACAAGTCCGGGTCGCTGTCGAACCTGCTGAACACCGCGGCGGCCAACGTCGACGGCAACGGCAAGGCCCTGCACGACACGATCACCAAGCTCGGCCAGGCGGCCGGCACGCTGTCGGGCAACAAGGACGACCTGTTCTCCACCGTCGAGAACCTCGGCAAGTTCTCGCAGACGCTGGCCGACTCCGACAAGCAGGTCCGCAGCTTCGAGAGCCAGCTCGCCGGCGTCAGCGGCTACCTGGCGTCCGAAAAGGACAACCTGGCCGCGACCGTGCAGCAGCTCGGCACGACGCTGACCGCGGTGCAGGCGTTCATCGACGCCAACCACGACCGGCTCAAGTCCAATGTGGACAAGCTGGCCGGCATCACCAAGGTGCTCGTCGACCAGCGCAGCTCGCTCGCCGAGATCCTCGACGTCGCCCCGGTCGGCCTGAGCAACCTGGTCAACACCTACAACGGCGCGGCGGGCACGCTCGACGCCCGGCCGAACCTCAACGAGCTGACCCAGCCGCCGCTGGTGATGATCTGCCGGCTGCTCAAGCAGGTCGGCAGCAAGGGCATTCCGGACGTGCTCGGCAACGCCTGCGAGAGCATCGCCGGCGTGGTCGACAAGGTGATCCCGCTGCCGTCCGTGGCGCAGACCGTGCAGGCCCTGCAGTCCGGTCAGCTGCCGCCGCTGCCGCTGCCCATCGCCGGGCAGCTCTACGGAGGTGGCCAGTGA	MSDTRFGLALTRGFTIAIVLALVVAGGIWWTLKDAGRNHLTAYFAGAVGLYEGNSVRMLGVDMGTVTKITPMGNQVKVDFEYDRSVAVPADAKALIVAPSLVSDRYVQLAPAYTGGPRISDGAVIGLDRTEVPLEVDQLAASLARVSETLGPNGANKSGSLSNLLNTAAANVDGNGKALHDTITKLGQAAGTLSGNKDDLFSTVENLGKFSQTLADSDKQVRSFESQLAGVSGYLASEKDNLAATVQQLGTTLTAVQAFIDANHDRLKSNVDKLAGITKVLVDQRSSLAEILDVAPVGLSNLVNTYNGAAGTLDARPNLNELTQPPLVMICRLLKQVGSKGIPDVLGNACESIAGVVDKVIPLPSVAQTVQALQSGQLPPLPLPIAGQLYGGGQ	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	112.57	gnl|BL_ORD_ID|761|hsp_num:0	786			270	384	vancomycin
BGC0000136.1|Rifamycin_10 # 8871 # 10043 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.689	BGC0000136.1|Rifamycin_10 	8871	10043	+	Loose	500	28.4906	OXY-2-5	40.68	3002400	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	OXY beta-lactamase	GTGAAGAAACTCCTGACCGTCGGGGTGCTGGCCACCGTGTCCGCGCTGGCGCTCTCCGGCTGTGCCTTCAAGGGCATCTACGACCTGCCGCTGCCCGGTGGCGCCGACCTCGGCGACCACCCGTACACGGTGAACGTCGAGTTCCGGGACGTGCTCGACCTGACCCCGCAGGCGGGGGTGAAGGTCGACGAGGTGCCGGTCGGCCGGGTCGAGAACGTCGGGCTCACCAAGGACGGCTGGCACGCGCTGGTCACCTTGCGGGTCAACGGCGACGTCAAGCTGCCGGCCAACGCGATCGCCAACGTCAAGCAGTCCAGCCTGCTCGGGGAGAAGTACGTCGAGCTGGCCTCGCCCGGCGCCGACCAGGCCCACGGCAAGCTCGCCGACAACGCGACCATCCCGCTGGCCCGCACGAACCGCAGCGTCGAGGTCGAAGAGCTGCTCGGGGCGCTGTCCCTGCTGCTCAACGGCGGTGGCGTCGACCAGCTGAACACCATCACCAAGGAGCTCAACAACGCCACGTCCGGCCGCGAGCCGGACATCAAGGCGTTGCTGGACAACGCGAACCAGCTGGTGACGAACCTCGACCGGCAGTCGAAGAACATCACCCGGGCCATCGACGGGCTGAACCGGCTCTCCTCGACCCTCAACGACCAGAAGGACAAGCTGGTCGGCGCGGTCGACAACCTCGGGCCCGGGCTCGGCGTGCTGGAGCAGCAGCGCGGCCAGCTGGTCACCATGCTGCAGGCGCTGGACAACCTCTCCGGCGTCGCCACCGACACGGTGAACAAGTCGCAGAAGGACCTCGTCGCCGACCTGAAGGCGCTGACGCCGACGCTGCAGAAGCTCGGCGAGGCGGGCAACGACCTGCCGAAGGCGCTGGAGATCCTGCTGACTTTCCCGTTCAGCGACCAGGCCGTCAACGGCGTCAAGGGCGACTACTTCAACCTGTTCGCGAAGGTGGACCTGAACCTGAAGACCGTCGTGGAGAACCTGGGCAACAGCCGGCAGAACGCCCTGTCCGGGCAGCTGCCGCTGGCCGGCCTGACCGGCGGGGTGCAGGGCACGCCGGCCAACCAGCCGCCACCGCTGCCGATCCCCGGCACCGGGCAGCAGCAGTCGAAGCCGGGCCTGGGCAACCTCTTCGGGCTCCTGCCGGGAGGTGCGGGCTGA	MKKLLTVGVLATVSALALSGCAFKGIYDLPLPGGADLGDHPYTVNVEFRDVLDLTPQAGVKVDEVPVGRVENVGLTKDGWHALVTLRVNGDVKLPANAIANVKQSSLLGEKYVELASPGADQAHGKLADNATIPLARTNRSVEVEELLGALSLLLNGGGVDQLNTITKELNNATSGREPDIKALLDNANQLVTNLDRQSKNITRAIDGLNRLSSTLNDQKDKLVGAVDNLGPGLGVLEQQRGQLVTMLQALDNLSGVATDTVNKSQKDLVADLKALTPTLQKLGEAGNDLPKALEILLTFPFSDQAVNGVKGDYFNLFAKVDLNLKTVVENLGNSRQNALSGQLPLAGLTGGVQGTPANQPPPLPIPGTGQQQSKPGLGNLFGLLPGGAG	MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTESTLNTAIPGDERDTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGSGDYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL	134.48	gnl|BL_ORD_ID|584|hsp_num:0	643			486	642	
BGC0000136.1|Rifamycin_11 # 10043 # 11308 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.703	BGC0000136.1|Rifamycin_11 	10043	11308	+	Loose	2300	27.7202	evgS	23.89	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGATCCGCCGGACGAAGATCCAGCTGATCGCCTTCGTGGTGATCTCGGTCGTCGCGATCGTGTACGCGCTGATCCGGTTCGCCGGGCTCGGCAGCGTGTTCGGCAACGACGGCTACACGGTGAAGTTGCAGCTCAACGAATCGGGCGGCATCTTCACCAACGCCGAGGTGACCTACCGCGGCTACAACATCGGCCGTGTCGGCGAAATGCGGCTCACCGCGACCGGGCTCGAGGCCGACCTCAACATCGACCCCTCGGCGCCGAAGGTACCCGCGGACCTCGATGCCGTCGTCGCCAACCGGTCGGCGGTCGGCGAGCAGTACGTCGACCTCAAGCCGAAGGCCGACCAGGGCCCCTACCTGGCGGCCGGCTCGGTGATCCCGGCGACCAAGACGACCACGCCGGTCAGCACCGACCGGCTGATCGGCGACCTCGACTCGCTCGCCGCGTCGGTCCCGGTCGACTCGCTGCGCACGGTCGTCGACGAGTCCTACGACGCCTTCCGCGGCACCGGCGGCGACCTGCAGAAGCTGCTGGACACCGCGCGCAGCTTCACCACGACGGCGCAGCAGTACCTGCCGCAGACGATCCAGCTGCTGGACGCCGGCGGCCAGGTGCTGGACACGCAGAACGCCGAGGCGGCGAACTTCGCCTCGTTCAGCAAGAGCCTCAACGAGCTCACCGGCACGCTGAAGAACTCCGACGGCGACCTGCGCAAGCTCATCGGGATCACCCCGCAGGTGGCGTCGCAGATCAGCCAGGTGCTGGCCGAATCCGGCCCGGGCCTGGGTGCGCTGACGGCGAACCTGCTCACCACGGCCAACCTGACCGTGACCCGCCTCGACGGGATCGAGCAGGGCCTGGTCACCTACCCGGCGCTGGCCGGCGCGGCGAGCAGCGTGGCGCCCGGCGACGGCACCGCGCACCTCGGCCTGGTGCTCAACCTGTTCAACCCGCCGGCCTGCACGAAGGGGTACCTGCCGTACTCGAAGTACCGCACCGGCAACGACCTCTCGGCGAAGCCGGCGAAGGAAGACGCGTACTGTGCCGAACCGAAGGGCAGCCCGATCAACGTCCGCGGGGCGCAGAACGCGCCCTACGGCGGGGTGCCGGTCGCGCCGTCGGACAGCGACGTCTCGGCCAACGCGAACCGGCCGGCGCAGGAGCTGGCCGAGGAGCGGGACACCCGGGGGGTGCCGGGCATCGTCGGCAGCCCCGGCGTCAGCCTGACCAGCCTGGGCTCGCTGCTCGGCCTGACCTGA	MLIRRTKIQLIAFVVISVVAIVYALIRFAGLGSVFGNDGYTVKLQLNESGGIFTNAEVTYRGYNIGRVGEMRLTATGLEADLNIDPSAPKVPADLDAVVANRSAVGEQYVDLKPKADQGPYLAAGSVIPATKTTTPVSTDRLIGDLDSLAASVPVDSLRTVVDESYDAFRGTGGDLQKLLDTARSFTTTAQQYLPQTIQLLDAGGQVLDTQNAEAANFASFSKSLNELTGTLKNSDGDLRKLIGITPQVASQISQVLAESGPGLGALTANLLTTANLTVTRLDGIEQGLVTYPALAGAASSVAPGDGTAHLGLVLNLFNPPACTKGYLPYSKYRTGNDLSAKPAKEDAYCAEPKGSPINVRGAQNAPYGGVPVAPSDSDVSANANRPAQELAEERDTRGVPGIVGSPGVSLTSLGSLLGLT	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	35.17	gnl|BL_ORD_ID|1214|hsp_num:0	1318			3279	3558	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000136.1|Rifamycin_12 # 11346 # 11921 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=4bp;gc_cont=0.693	BGC0000136.1|Rifamycin_12 	11346	11921	+	Loose	1000	27.335	MCR-3.15	29.23	3007252	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAGCACGGACGAGCCGGCCGCCACGTCGGTAGCGGAAGAGTCTTCCGCGGCGCCGCCGAAGGACGCCTCGCGGACCCTGGTGCTCGGCGCCGCGGCACTGGCACTGGCCGCCCTCATCGCGGCGGCGATCTTCGGCGTCCAGTGGTGGATGGCCGCGAACGACGACAACGCCGGCCTGGCGGCGTCGCGCGAGGCCGTGGTGAAGGCGGGCACCAACGCGCTGAAGGCCTACACCGAGGTCGACTACACCGATCTCGACGGCTTCTTCACCCGGCAGAAGGCCGTGTCGGACGAGAAGATGTCGCAGCAGATCGACCAGTCGGCGCCGACGTTCCGCAAGGCCCTCGCCGACGCCAAGACGAAGGTCACCACGGACGTCCAGGACGTCGCCGTCGAGGAGCTGGACGACCACGAAGGCAAGGCCAGCTTCCTCGCCGCCATCGCCACCACCGTCACCCAGGGGGACAAGAGCAGCGCGAAGCCGTTGCGCCTCGAAGTCTCGATGAGCAAGGTGGGCGAGGATTGGAAGCTGTCCGGCATCGACAGCGTCCCGCTCGTCGCGGCCGGCCAGTAG	MSTDEPAATSVAEESSAAPPKDASRTLVLGAAALALAALIAAAIFGVQWWMAANDDNAGLAASREAVVKAGTNALKAYTEVDYTDLDGFFTRQKAVSDEKMSQQIDQSAPTFRKALADAKTKVTTDVQDVAVEELDDHEGKASFLAAIATTVTQGDKSSAKPLRLEVSMSKVGEDWKLSGIDSVPLVAAGQ	MPSLIKIKIVPLIFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNFVFVPFSIRYLVKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLTIIGWVTIAGFIPAILLFFVEIEYEEKWFKGILTRVLSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVKYVYNRYFAEPIPFTTLGDDAKRDTNKSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDVRSCGTATAVSVPCMFSNMGRKEFDDNLARNSEGLLDVLQKTGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPKFCDKNTCYDEVVLQDLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRIDIENCTDEELTNTYDNTIRYTDLVIAEMIAKLKNYEDKYNTALLYVSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQIWMSPGFIKEKGMNMECLQKNATTNRYSHDNIFSSVLGIWDVKTAIYEQELDIFKQCRNN	35.37	gnl|BL_ORD_ID|4872|hsp_num:0	5857			1047	1233	colistin A; colistin B
BGC0000136.1|Rifamycin_15 # 14275 # 15309 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=14bp;gc_cont=0.743	BGC0000136.1|Rifamycin_15 	14275	15309	+	Loose	200	34.6538	vanH gene in vanF cluster	33.72	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	TTGGTAATGGCTCCCACCGGCGGCGTGGGCGAGTCTCGATACGTGAAGACGTTGCGGCAGCTCGAGGTGGCCCTGATCGGTGCGGGGCTCATCGCCCGGCTGCACCTGGAAGCGTGGCTCGGCGCCGGCGCCGCCGTGCGGGTGTACTCCGACGACGGCCGGAGCCGCGAGCTGGCGGCGGAGTTCGGCGCGAAGGCCGCCGGGTCCCTGGAAGAGGCGCTCGACGGCGCCGACGCCGTCGACATCTGCACGCCGACCGCGAGCCACCACGAGATCGCCCTGACCGCCATCGCCGCCGGTGTCGGCGTCGTGTGCGAGAAGCCGCTGGCGGCCAGCGCCGAAGAGGCCGAAGAGATCGTCACCGCCGCCGAACGGGCCGGGGTGCGGCTCTACGCCGCCCACGACGTGCGGTTCGCGGCGCCCTACGCGCGATTGCACGAGCTCGTTGCGAGCGGGCGGCTCGGGGAGGGTGCCCTCGGCCGGTTCTCCTTCTCCGCCTACCACCCGCGGCCCTGGACCGGGCACGCCTCCGCGCGGTCGGGCGGCATCCTCACCGACCAGCTGCTGCACGGCGCCGACCTCGCCCACTGGGTCTTCGGGGACGTCGTCCGCGTGCACGCCTGCTACCAGGGCGACATCGCCACCCCGGCGCCCGAAGGGGCCGTCGCGACCGGGACCGCCGTGCTCACCCACGCGAGCGGCGCCATCAGCCAGGTGGTGAGCCGGTGGACGGCCACGCCGCGGCCGCCGGTGCGGGTGGCCTTCCACGTCTCGGGTACCGGCGGGTCCGTCAGCTACGACTCCGAGTGGCCGCAGGAGGTCCGGGTCGTCGACGGCGGCGCCGGGAACTTCGCTTACGGCGGGCCGTCGGTGTTCGACACCGAAATGCGGGAGTTCGCCACGGCTTTCGCGGGTGGACCCGAGCCGAGGATCGGCGCGAAGGACGCGCTGGCCGCCGTGCGGATCATCCACGCCGCCGCCGAGTCCGCGTGGACCGGGCGGGCCGTCGAACTGCCGGTGAGGGGAGCAGCGTGA	MVMAPTGGVGESRYVKTLRQLEVALIGAGLIARLHLEAWLGAGAAVRVYSDDGRSRELAAEFGAKAAGSLEEALDGADAVDICTPTASHHEIALTAIAAGVGVVCEKPLAASAEEAEEIVTAAERAGVRLYAAHDVRFAAPYARLHELVASGRLGEGALGRFSFSAYHPRPWTGHASARSGGILTDQLLHGADLAHWVFGDVVRVHACYQGDIATPAPEGAVATGTAVLTHASGAISQVVSRWTATPRPPVRVAFHVSGTGGSVSYDSEWPQEVRVVDGGAGNFAYGGPSVFDTEMREFATAFAGGPEPRIGAKDALAAVRIIHAAAESAWTGRAVELPVRGAA	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	106.83	gnl|BL_ORD_ID|1652|hsp_num:0	1790			423	657	vancomycin
BGC0000136.1|Rifamycin_17 # 16262 # 16477 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=5bp;gc_cont=0.653	BGC0000136.1|Rifamycin_17 	16262	16477	+	Loose	580	22.7126	SHV-216	41.67	3005215	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGAGTGTTACGCAGGTGAAAATCGCGTTGAGCGGTGGACCGGCCGAACTGGCGCCGGCGCACCGCAGCGTCGACTCCGGCGCGCTGGAGAACACGCTCAAGATCCGCCACGGGGCCGGTTACGAGCATTTCGTGCACGGCGGCGAATTCCAGGCCGTCGACGGCTGCGACATCGCGGTCTTCCGGTGGTCGCACCGCACGAAGATCGCCGAATAA	MSVTQVKIALSGGPAELAPAHRSVDSGALENTLKIRHGAGYEHFVHGGEFQAVDGCDIAVFRWSHRTKIAE	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAELTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	24.83	gnl|BL_ORD_ID|2910|hsp_num:0	3930			384	456	
BGC0000136.1|Rifamycin_18 # 16510 # 17700 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.693	BGC0000136.1|Rifamycin_18 	16510	17700	+	Loose	650	28.8758	MexA	33.33	3000377	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGACGCAATATCCTTCGAGGTGCCGTGGGACCGGACCGACAAGTTCGACCCGCCCGCGGTGTTCGACTCTCTGCGCGAAGAACGTCCGCTCGCGAAGATGGTTTACCCGGATGGGCACGTCGGCTGGATCGTTTCCAGCTACGAGCTGGTCCGCGAGGTCCTCAGCGACCTGCGGTTCAGCCACAGCTGCGAAGTCGGCCACTTCCCGGTGACCCACCAGGGCCAGGTCATCCCGACCCACCCGCTGATCCCCGGCATGTTCATCCACATGGACCCGCCCGAGCACACGCGCTACCGCAAGCTGCTGACCGGCGAGTTCACCGTCCGCCGCGCCAGCAGGCTGATCCCGCGGGCCGAGGCCGTGGCCGCCGAGCAGATCGAGGTCATGCGGGCCAAGGGCGCCCCCGCGGACGTGGTCATGGACTTCGCCAAGCCGCTGGTGCTGCGGATGCTGGGCGAGCTCGTCGGCCTGCCCTACGAGGAACGCGACCGGTACGTGCCCGCGGTGACCCTCCTGCACGACGCCGAAGCGGACCCGGCCGAGGCCGCGGCCGCCTACGAGGTGGCCGGGAAGTTCTTCGACGAGGTCATCGAGCGCCGCCGGCAGCGGCCCCAGGACGACCTCATCAGCTCGCTCGTCACCGAGGACCTGACCCAGGAGGAGCTGCGCAACATCGTCACCCTGCTGCTGTTCGCCGGGTACGAGACCACCGAGGGCGCGCTCGCCACCGGCGTCTTCGCGCTGCTGCACCACACCGATCAGCTGGCGGCACTGCGCGCGGAGCCGGAAAAGCTCGACGCCGCGATCGAAGAGCTGCTGCGCTACCTGACCGTCAACCAGTACCACACCTACCGCACCGCGCTGGAGGACGTGAAGCTGGAGGGCGAGCTGATCAAGAAGGGCGACACGGTGACGGTGTCGCTGCCCGCGGCCAACCGCGACCCGGCCAAGTTCGGCTGTCCCGCGGAGCTCGACATCGAGCGGGACACCTCCGGCCACGTCGCGTTCGGCTTCGGCATCCACCAGTGCCTGGGCCAGAACCTGGCGCGCATCGAGCTGCGGGCCGGCTTCACGGCGCTCCTGCGGGCGTTCCCCGAGCTCCGGCTGGCCGTCCCGGCCGACGAGGTTCCGCTGCGGCTGAAGGGTTCCGTCTTCTCGGTGAAGAAGCTGCCCGTCTCCTGGTGA	MTDAISFEVPWDRTDKFDPPAVFDSLREERPLAKMVYPDGHVGWIVSSYELVREVLSDLRFSHSCEVGHFPVTHQGQVIPTHPLIPGMFIHMDPPEHTRYRKLLTGEFTVRRASRLIPRAEAVAAEQIEVMRAKGAPADVVMDFAKPLVLRMLGELVGLPYEERDRYVPAVTLLHDAEADPAEAAAAYEVAGKFFDEVIERRRQRPQDDLISSLVTEDLTQEELRNIVTLLLFAGYETTEGALATGVFALLHHTDQLAALRAEPEKLDAAIEELLRYLTVNQYHTYRTALEDVKLEGELIKKGDTVTVSLPAANRDPAKFGCPAELDIERDTSGHVAFGFGIHQCLGQNLARIELRAGFTALLRAFPELRLAVPADEVPLRLKGSVFSVKKLPVSW	MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAFRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRYKLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTNGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPLEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRDLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTVPAKNVASAQKADAAPAKTDSKG	103.39	gnl|BL_ORD_ID|438|hsp_num:0	440			801	900	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000136.1|Rifamycin_19 # 17741 # 31948 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.737	BGC0000136.1|Rifamycin_19 	17741	31948	+	Loose	1000	114.39	almE	25.29	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGCGCACCGATCTCATCAAGCCACTTCACGTCGCACTCCTGGAGAACGCGACCCGCTTCGCCGGCAAGCCGGCCTTCGCCGACGACCACCGGACGGTCACCTACGGCGACCTCGAGGCGCGGACGCGCCGGCTGGCCGGGCACCTGGCCGGCCTCGGTGTCCGGCACGGCGACCGGGTGGCGATCTGCCTCGGCAACCGGGTGTCCACTGTGGAGAGTTACTTCGCGATCCTGCGCGCGGGTGCCGTCGGCGTGCCGCTCAACCCCGGTTCGGCGACGGCCGAGCTCGAGCACCCGCTGACCGACAGCGGCGCCACGGTGGTCGTCACCGACGCCGCCCAGGCGGCCCGGCTCCGGCTCGCGCCGCACGTCGAGCTGCTGGTGACCGGCGACGACGTCCCGGAGGGCGCCCACTCCTACGACGAACTCGCCCTCAGCGAACCGGCCGAGCCCGCCGCGGACGACCTCGAGCTCGACGAGCCGGCGTGGATGTTCTACACGTCGGGCACGACCGGGCGGCCCAAGGGCGTCGTGTCCACGCAGCGCAACTGCCTCTGGTCCGTCGCTTCCTGCTACGTGCCGTTCCCCGGGTTGTCGGACCAGGACCGGGTGCTCTGGCCGCTCCCGCTGTTCCACAGCCTTTCGCACATCGCCTGCGTCCTGTCCGCCACCGTGGTCGGGGCCAGCGTCCGGATCGCCGACGGCAGCTCCGCCGACGACGTGATGCGGCTGATCGAGGCGGAGAGCTCGACCTTCCTGGCCGGCGTGCCGACCACCTACCACCACCTGGTGCGGGCCGCCCGGCAGCGCGGTTTCTCCGCGCCGAGCCTGCGGATCGGCCTGGCCGGGGGCGCGGTCCTCGGCGCCGGGCTGCGAAGCGAGTTCGAAGAGACCTTCGGGGTCCCGCTGATCGACGCCTACGGCAGCACCGAGACCTGCGGGGCGATCACCATGAACCCGCCGGACGGCGCCCGCGTCGAGGGCTCGTGCGGCTTGGCCGTGCCGGGCGTCGACGTGCGGGTCGTCGACCCCGACACCGGGCTCGACGTCCCCGCCGGCGAGGAGGGCGAGGTCTGGGTCAGCGGGCCGAACGTCATGCTCGGCTACCACAACAGCCCGGAGGCGACCGCCGCGGCGATGCGGGACGGCTGGTTCCGGACCGGGGACCTGGCCCGCCGCGACGACGCCGGTTACTTCACCATCTGCGGCCGGATCAAGGAACTCATCATCCGCGGCGGCGCGAACATCCACCCCGGCGAGGTCGAGGCGGTCCTGCGCACGGTCGACGGCGTCGCGGACGCGGCGGTCGGCGGTGTGCCGCACGACACGCTCGGCGAGGTGCCGGTCGCCTACGTCATCCCCGGACCGACCGGTTTCGATCCTGCGGCGTTGATCGAGAAGTGCCGCGAACAGCTGTCCGCCTACAAGGTGCCGGACCGGATCCTCGAGGTCGCCCACATTCCCCGGACCGCGTCGGGCAAGATCCGGCGCGGGCTGCTGACCGACGAGCCCGCGCAGCTGCGGTACGCCGCGACCGAACACGAGGAACAGTCCCGGCACGCCGACGAGTCCGTCGCGGCGGCGCTGCGCGCGCGACTGTCCGGTTTGGACGAACGCGCCCAGTGCGAGCTCCTGGAAGACCTCGTCCGCACCCAGGCGGCCGACGTGCTGGGGCAGCCGGTCCCGGACGGGCGTGCGTTCCGCGACCTCGGCTTCACGTCGCTGGCCATCGTGGAGCTGCGCAACCGGCTGACCGAGCACACCGGGCTCTGGCTGCCCGCCAGCGCCGTCTTCGACCACCCCACGCCGGCGGCGCTGGCCGCCCGCGTCCGGGCTGAGCTCCTCGGGATCACGCAGGCCGTCGCGGAGCCGGTCGTCGCGGCCGACCCGGGCGAGCCGATCGCGATCGTGGGGATGGCCTGCCGCCTGCCGGGTGGCGTGGCGTCCCCGGAAGACCTGTGGCGGCTGGTGGCCGAGCGCGTCGACGCCGTTTCGGAGTTCCCCGGCGACCGCGGCTGGGACCTGGACAGCCTGATCGACCCGGACCGGGAGCGCGCCGGGACGTCGTACGTCGGCCAGGGCGGATTCCTGCACGACGCCGGCGAGTTCGACGCCGGGTTCTTCGGGATCTCGCCGCGTGAGGCCGTCGCGATGGACCCGCAGCAGCGGTTGCTGCTGGAGACGTCGTGGGAGGCCCTCGAAAACGCCGGAGTCGACCCGATCGCGTTGAAGGGCACCGACACCGGCGTGTTCTCCGGCCTCATGGGCCAGGGGTACGGGTCCGGCGCGGTGGCGCCGGAGCTCGAAGGTTTCGTCACCACCGGGGTCGCGTCGAGCGTGGCCTCGGGCCGGGTGTCGTACGTGCTGGGACTGGAAGGCCCGGCGGTCACCGTGGACACCGCGTGTTCGTCGTCGCTGGTCGCGATGCACCTGGCCGCGCAGGCCCTGCGGCAGGGCGAATGCTCGATGGCGCTCGCCGGCGGGGTCACGGTGATGGCCACGCCGGGCTCGTTCGTCGAGTTCTCCCGCCAGCGGGCCCTGGCGCCCGACGGGCGCTGCAAGGCCTTCGCGGCGGCGGCCGACGGGACCGGCTGGTCCGAGGGTGTCGGCGTGGTCGTCCTCGAGCGGCTGTCCGTGGCGCGCGAGCGGGGCCACCGGATCCTGGCCGTTTTGCGTGGCAGCGCGGTCAACCAGGACGGCGCGTCCAACGGGCTCACCGCGCCGAACGGCCTCTCGCAGCAGCGGGTCATCCGCCGCGCGCTGGCCGCGGCCGGGCTGGCACCGTCCGATGTGGACGTCGTCGAGGCGCACGGCACCGGGACCACGCTGGGTGACCCGATCGAGGCGCAGGCCCTGCTGGCGACCTACGGCCAGGAGCGGAAGCAGCCGTTGTGGCTCGGTTCGCTCAAGTCGAACATCGGCCACGCGCAGGCGGCCGCGGGCGTTGCGGGCGTCATCAAGATGGTGCAGGCGCTGCGGCACGAGACCTTGCCGCCGACGCTGCATGTCGACAAGCCGACTCTTGAGGTGGACTGGTCCGCCGGTGCCATTGAACTGCTGACGGAGGCCCGTGCGTGGCCGCGCAACGGCCGTCCGCGCCGGGCCGGGGTGTCGTCGTTCGGCGTCAGCGGGACCAACGCGCACCTGATCCTGGAGGAGGCGCCGGCCGAGGAGCCGGTCGCTGCCCCGGAACTGCCGGTGGTGCCCCTGGTGGTGTCGGCGCGGAGCACGGAGTCGCTGTCCGGGCAGGCCGAGCGGCTGGCGTCCCTCCTCGAAGGGGACGTCTCGCTGACCGAGGTGGCCGGGGCGCTGGTGTCCCGCCGGGCGGTGCTGGACGAGCGGGCCGTCGTCGTGGCCGGTTCGCGCGAGGAAGCCGTGACCGGGCTGCGGGCGCTGAACACGGCCGGTTCGGGGACGCCGGGCAAGGTCGTGTGGGTGTTCCCGGGGCAGGGGACGCAGTGGGCCGGGATGGGCCGTGAGCTGCTGGCCGAGTCCCCGGTGTTCGCCGAGCGGATCGCCGAGTGCGCGGCCGCGTTGGCGCCGTGGATCGACTGGTCGCTCGTCGACGTCCTGCGCGGCGAGGGCGACCTGGGTCGGGTCGATGTGCTGCAGCCGGCCTGTTTCGCGGTGATGGTCGGGCTGGCTGCCGTCTGGGAGTCCGTGGGGGTCCGGCCGGACGCCGTCGTCGGGCACTCGCAGGGTGAGATCGCGGCTGCCTGCGTTTCGGGGGCGTTGTCCCTCGAGGACGCGGCGAAGGTGGTGGCCCTGCGCAGCCAGGCCATCGCGGCGGAACTGTCCGGCCGCGGCGGGATGGCGTCGGTCGCCCTGGGCGAGGACGACGTCGTTTCGCGGCTGGTGGACGGGGTCGAGGTCGCCGCCGTCAACGGCCCGTCGTCGGTGGTGATCGCCGGGGATGCCCATGCCCTCGACGCGACCCTGGAAATCTTGTCCGGGGAAGGCATCCGGGTTCGGCGGGTGGCGGTGGACTACGCCTCGCACACCCGGCATGTCGAGGACATCCGCGACACTCTTGCCGAAACCTTGGCCGGGATCAGTGCGCAGGCGCCGGCTGTGCCGTTCTACTCCACCGTCACGAGCGAGTGGGTGCGCGACGCGGGGGTGCTGGACGGCGGCTACTGGTACCGGAACCTGCGCAACCAGGTCCGGTTCGGAGCGGCCGCGACGGCCCTGCTCGAGCAGGGCCACACGGTGTTCGTCGAGGTCAGTGCGCACCCGGTGACGGTCCAGCCCTTGAGCGAGCTCACCGGGGACGCGATCGGGACATTGCGGCGTGAAGACGGTGGCCTGCGGCGGTTGCTGGCTTCGATGGGTGAGCTGTTCGTCCGCGGCATCGACGTGGACTGGACGGCGATGGTGCCCGCGGCCGGCTGGGTCGACTTGCCGACCTACGCGTTCGAACACCGGCACTACTGGCTCGAGCCCGCCGAGCCCGCTTCGGCCGGAGACCCGCTGCTGGGCACAGTCGTCAGCACTCCCGGTTCGGACCGACTCACCGCCGTGGCGCAGTGGTCGCGCCGGGCGCAGCCCTGGGCGGTGGACGGCCTGGTGCCGAACGCGGCCCTGGTCGAGGCGGCCATCCGGCTCGGCGACCTGGCCGGCACCCCCGTCGTCGGCGAACTGGTCGTCGACGCGCCGGTGGTGCTGCCGCGGCGCGGCAGCCGCGAGGTCCAGCTGATCGTCGGCGAGCCCGGCGAGCAGCGGCGGCGTCCGATCGAGGTCTTTTCCCGGGAAGCCGACGAGCCGTGGACGCGGCACGCGCACGGCACACTCGCTCCCGCCGCCGCTGCGGTGCCAGAACCGGCGGCGGCGGGAGACGCCACCGACGTCACCGTGGCCGGCCTGCGCGACGCGGACCGGTACGGGATCCACCCCGCGCTGCTGGACGCCGCCGTCCGCACGGTCGTCGGCGACGACCTGCTCCCGTCGGTGTGGACCGGCGTGTCCCTGCTGGCCTCCGGGGCCACGGCCGTGACCGTGACGCCGACGGCGACCGGCCTGCGGCTGACCGACCCGGCCGGGCAGCCCGTCCTGACCGTCGAATCCGTGCGCGGCACGCCGTTCGTCGCCGAGCAGGGGACCACCGACGCGCTCTTCCGCGTCGACTGGCCGGAAATCCCGCTGCCCACCGCCGAAACCGCGGACTTCCTGCCGTACGAAGCCACGTCGGCCGAGGCGACCCTCTCCGCGCTCCAGGCCTGGCTGGCAGACCCCGCGGAAACCCGGCTGGCCGTGGTCACCGGGGACTGCACCGAACCCGGCGCGGCCGCGATCTGGGGCCTGGTGCGCTCGGCGCAGTCCGAACACCCCGGCCGGATCGTGCTGGCCGACCTCGACGACCCCGCCGTGCTGCCCGCCGTGGTGGCGAGCGGCGAACCGCAGGTGCGGGTGCGCAACGGCGTCGCCTCGGTGCCGCGCTTGACCCGGGTTACTCCCCGGCAGGACGCGCGGCCGCTCGACCCCGAGGGCACCGTCCTGATCACCGGCGGCACCGGCACGCTCGGTGCGCTGACCGCCCGGCACCTCGTCACCGCGCACGGCGTCCGGCACCTGGTGCTGGTCAGCCGCCGCGGTGAGGCTCCCGAGCTGCAGGAAGAACTGACCGCACTGGGGGCATCCGTCGCCATCGCCGCCTGCGACGTGGCAGACCGGGCGCAGCTCGAAGCCGTCTTGCGCGCGATCCCGGCCGAGCACCCGCTCACCGCCGTGATCCACACCGCGGGGGTCCTCGACGACGGCGTCGTCACCGAGCTGACCCCGGACCGGCTCGCCACCGTGCGGCGGCCGAAGGTCGACGCCGCCCGGCTCCTGGACGAGCTCACCCGGGAGGCCGATCTCGCCGCGTTCGTGCTGTTCTCCTCGGCGGCGGGTGTGCTGGGCAACCCCGGCCAGGCCGGGTACGCCGCCGCCAACGCCGAGCTGGATGCGTTGGCGCGCCAGCGGAACAGCCTCGACCTGCCCGCGGTGTCCATCGCATGGGGCTACTGGGCGACGGTCAGCGGGATGACCGAGCACCTGGGCGACGCCGACCTGCGGCGCAACCAGCGGATCGGCATGTCCGGGCTTCCCGCCGACGAGGGCATGGCGCTGCTGGACGCCGCCATCGCCACCGGTGGCACGCTGGTCGCGGCCAAGTTCGACGTCGCCGCGCTGCGGGCGACGGCGAAGGCCGGCGGCCCGGTGCCGCCGCTGCTGCGTGGCCTGGCCCCGCTGCCGCGCCGGGCGGCGGCCAAGACCGCGTCGCTGACCGAACGCCTCGCCGGGCTGGCCGAGACCGAGCAGGCCGCGGCCCTGCTCGACCTGGTCCGGCGGCACGCCGCCGAGGTGCTCGGGCACAGCGGCGCCGAATCCGTCCATTCAGGACGGACGTTCAAGGACGCCGGCTTCGACTCGCTGACCGCGGTGGAACTGCGGAACCGCCTCGCGGCCGCGACCGGGCTCACCCTGTCCCCGGCGATGATCTTCGACTACCCGAAGCCCCCGGCGCTCGCGGACCACCTGCGCGCCAAGCTCTTCGGATCGGCGGCGAACCGGCCGGCCGAGATCGGCACCGCCGCGGCCGAGGAGCCGATCGCGATCGTCGCGATGGCGTGCCGCTTCCCCGGTGGCGTGCACAGCCCCGAGGACCTGTGGCGGCTGGTCGCCGACGGCGCCGACGCCGTCACCGAGTTCCCCGCCGACCGCGGCTGGGACACCGACCGGCTCTACCACGAAGACCCCGACCACGAAGGCACGACGTACGTCCGGCACGGCGCCTTCCTCGACGACGCCGCCGGGTTCGACGCCGCCTTCTTCGGCATCTCGCCGAACGAGGCGCTCGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGACGTCCTGGGAGCTGTTCGAGCGGGCCGCGATCGACCCGACCACGCTGGCCGGCCAGGACATCGGCGTCTTCGCCGGCGTCAACAGCCACGACTACAGCATGCGGATGCACCGGGCCGCCGGTGTCGAGGGCTTCCGGCTCACCGGCGGTTCGGCCAGCGTGCTCTCCGGCCGCGTCGCCTACCACTTCGGCGTCGAAGGCCCGGCCGTCACGGTCGACACGGCCTGCTCGTCTTCGCTGGTCGCGCTGCACATGGCGGTGCAGGCCCTGCAGCGCGGCGAGTGCTCCATGGCGCTCGCGGGCGGCGTGATGGTGATGGGCACGGTCGAGACGTTCGTCGAGTTCTCGCGGCAGCGCGGGCTGGCCCCCGACGGCCGCTGCAAGGCGTTCGCCGACGGCGCGGACGGCACCGGCTGGTCCGAGGGCGTCGGGCTGCTCCTGGTGGAGCGGCTGTCCGAGGCTCAGCGTCGCGGGCACCAGGTCCTCGCCGTGGTCCGCGGGTCGGCGGTCAACTCCGACGGCGCGTCGAACGGCTTGACGGCCCCGAACGGCCCGTCCCAGCAGCGCGTGATCCGCAAGGCACTGGCCGCCGCCGGACTGTCCACATCGGACGTCGACGCGGTGGAGGCGCACGGCACCGGGACGACCCTGGGCGACCCGATCGAGGCCGAGGCGCTGCTGGCCACCTACGGCCAGAACCGGGAAACGCCGCTGTGGCTCGGGTCGGTGAAGTCGAACCTCGGGCACACGCAGGCGGCTGCGGGTGTCGCAGGCGTGATCAAGATGGTCATGGCCATGCGCCACGGCGTCCTGCCCCGGACGCTGCACGTCGACCGGCCGTCGTCCTATGTGGACTGGTCGGCCGGTGCGGTCGAGCTGCTGACCGAGGCACGGGACTGGGTGAGCAACGGCCACCCGCGCCGCGCGGGCGTGTCGTCGTTCGGCATCGGCGGCACCAACGCGCACGTCGTCCTCGAAGAGGTTGCCGCACCGATCACCACGCCGCAGCCTGAGCCGGCCGAGTTCCTGGTGCCGGTGCTCGTCTCCGCGCGGACGGCGGCGGGTCTGCGCGGCCAGGCCGGACGGCTCGCCGCGTTCCTCGGCGACCGGACCGACGTCCGCGTCCCCGATGCCGCCTACGCACTGGCCACCACGCGCGCCCAGCTCGACCACCGGGCCGTCGTCCTGGCCTCCGACCGGGCACAGCTCTGCGCGGACCTTGCCGCGTTCGGCTCCGGCGTCGTGACCGGAACGCCGGTTGACGGCAAGCTGGCCGTGCTCTTCACCGGCCAGGGCAGCCAGTGGGCCGGGATGGGCCGTGAACTCGCCGAGACGTTCCCGGTCTTCCGCGACGCCTTCGAGGCCGCGTGCGAGGCCGTGGACACGCACCTGCGTGAGCGTCCGCTGCGCGAGGTCGTGTTCGACGACAGCGCGCTGCTCGACCAGACGATGTACACCCAGGGCGCCCTGTTCGCCGTGGAGACCGCGTTGTTCCGGCTCTTCGAGTCCTGGGGTGTGCGGCCGGGTCTCCTCGCCGGTCACTCGATCGGCGAGCTCGCCGCCGCGCACGTGTCCGGCGTGCTGGACCTGGCCGACGCGGGCGAGCTGGTCGCCGCGCGCGGCCGGCTGATGCAGGCCCTGCCCGCGGGCGGCGCGATGGTCGCCGTCCAGGCGACCGAGGACGAAGTCGCGCCCCTGCTCGACGGCACGGTCTGCGTCGCCGCGGTCAACGGTCCGGACTCGGTGGTGCTCTCCGGCACCGAAGCCGCCGTGCTCGCCGTCGCGGATGAACTGGCTGGTCGCGGCCGTAAGACCCGACGGCTGGCCGTGAGCCACGCCTTCCACTCGCCGCTCATGGAACCGATGCTCGACGACTTCCGCGCGGTCGCCGAACGCCTGACGTACCGGGCCGGTTCGCTGCCCGTCGTCTCGACGCTGACCGGGGAACTCGCGGCGCTCGACAGCCCGGACTACTGGGTCGGCCAGGTGCGCAACGCCGTGCGGTTCAGCGACGCCGTCACCGCGCTGGGCGCCCAAGGCGCGTCGACGTTCCTCGAGCTCGGCCCGGGCGGTGCGCTCGCCGCGATGGCGCTCGGCACGCTCGGCGGACCCGAGCAGAGCTGCGTCGCGACCCTGCGCAAGAACGGCGCCGAGGTGCCCGACGTCCTCACCGCGCTCGCCGAACTGCACGTCCGGGGCGTGGGCGTCGACTGGACGACCGTGCTCGACGAACCGGCCACGGCGGTCGGGACCGTCCTGCCCACCTACGCGTTCCAGCACCAGCGCTTCTGGGTCGACGTCGACGAAACAGCGGCCGTCAGCGTCACCCCGCCGCCGGCGGAGCCGATCGTGGACCGGCCGGTGCAGGACGTGCTGGAGCTGGTCCGGGAGAGCGCCGCGGTGGTGCTCGGGCACCGGGACGCCGGCAGTTTCGACCTCGACCGGTCCTTCAAGGACCACGGCTTCGACTCGCTCAGCGCGGTCAAGCTGCGCAACCGTCTGCGCGACTTCACCGGCGTGGAGCTGCCCAGCACCCTGATCTTCGACTACCCGAACCCGGCCGTCCTCGCGGACCACCTGCGGGCCGAACTGCTCGGCGAGCGCCCGGCCGCGCCGGCCCCGGTGACGAGGGACGTCTCCGACGAGCCGATCGCGATCGTCGGCATGAGCACCCGGCTGCCGGGTGGCGCCGACAGCCCCGAAGAGCTGTGGAAGCTCGTCGCGGAGGGACGGGACGCCGTGTCCGGCTTCCCCGTCGACCGCGGCTGGGACCTCGACGGCCTCTACCACCCGGACCCCGCCCACGCCGGGACGAGCTACACGCGTTCGGGCGGCTTCCTGCACGACGCGGCCCAGTTCGACGCCGGGCTCTTCGGGATCTCACCGCGTGAGGCCCTGGCCATGGACCCGCAGCAGCGGCTGCTGCTGGAGACGTCGTGGGAAGCCTTGGAGCGCGCGGGGGTCGACCCGCTGTCCGCCCGCGGCAGCGACGTCGGCGTCTTCACCGGGATCGTCCACCACGACTACGTGACGCGGCTGCGCGAAGTGCCCGAAGACGTCCAGGGCTACACGATGACCGGCACGGCTTCGAGCGTGGCGTCGGGCCGGGTGGCGTACGTCTTCGGCTTCGAGGGCCCGGCGGTCACCGTGGACACCGCGTGTTCGTCGTCGCTGGTCGCGATGCACCTGGCGGCGCAGGCGCTGCGGCAGGGGGAGTGCTCGATGGCCCTGGCCGGCGGCGCGACCGTGATGGCCAGCCCGGACGCCTTCCTCGAGTTCTCCCGCCAGCGCGGCCTGTCCGCGGACGGCCGGTGCAAGGCGTACGCGGAAGGCGCGGACGGCACGGGCTGGGCCGAGGGCGTCGGTGTCGTCGTCCTCGAACGGCTTTCGGTGGCACGCGAACGTGGCCACCGGGTGCTGGCGGTCCTGCGCGGCAGCGCGGTGAACCAGGACGGTGCTTCCAACGGCCTGACCGCCCCGAACGGGCCGTCGCAGCAGCGGGTGATCCGCGGCGCGCTGGCGAGCGCCGGGCTGGCACCGTCCGATGTGGACGTCGTGGAGGGCCACGGGACCGGGACCGCGCTGGGTGACCCGATCGAGGTCCAGGCGCTGCTGGCCACCTACGGGCAGGAGCGGGAACAGCCGTTGTGGCTCGGCTCGCTGAAGTCGAACCTCGGGCACACGCAGGCCGCGGCCGGGGTCGTGGGCGTGATCAAGATGATCATGGCCATGCGCCACGGCGTCATGCCGGCCACGCTGCACGTCGACGAGCGCACGAGCCAGGTCGACTGGTCGGCGGGCGCGATCGAGGTGTTGACCGAGGCCCGGGAGTGGCCGCGCACCGGACGTCCGCGCCGGGCCGGGGTGTCCTCCTTCGGCGCCAGCGGCACCAACGCGCACCTGATCATCGAGGAAGGTCCCGCCGAAGAGGCCGTGGACGAAGAGGTGGCCTCCGTGGTGCCGCTGGTCGTCTCCGCCCGCAGCGCCGGTTCGCTGGCCGGGCAGGCCGGGCGCCTGGCCGCGGTCCTCGAGAACGAATCGTTGGCCGGGGTGGCCGGTGCCCTGGTTTCCGGCCGCGCGACGCTGAACGAGCGCGCGGTCGTCATCGCGGGCTCCCGCGACGAGGCCCAGGACGGCCTGCAGGCACTGGCCCGCGGCGAGAACGCGCCCGGCGTCGTGACCGGGACGGCGGGCAAGCCGGGCAAGGTCGTCTGGGTCTTCCCCGGCCAGGGCTCGCAGTGGATGGGCATGGGCCGGGACCTCCTGGACTCCTCGCCGGTGTTCGCCGCGCGGATCAAGGAATGCGCTGCGGCACTGGAACAGTGGACCGACTGGTCGCTGCTGGACGTGCTGCGCGGCGACGCCGACCTGCTGGACCGGGTCGACGTGGTGCAGCCGGCCAGCTTCGCGATGATGGTCGGGCTCGCCGCGGTGTGGACCTCGCTGGGGGTGACCCCGGATGCGGTGCTCGGCCACTCCCAGGGCGAGATCGCCGCGGCGTGCGTGTCCGGCGCGCTGTCGCTGGACGACGCGGCGAAGGTGGTCGCGTTGCGCAGCCAGGCGATCGCGGGGGAGCTGGCGGGCCGCGGCGGGATGGCGTCGGTCGCACTGAGCGAAGAGGACGCAGTCGCGCGGCTGACGCCGTGGGCGAACCGGGTCGAGGTGGCCGCGGTCAACAGCCCGTCCTCGGTCGTCATCGCGGGAGACGCGCAGGCCCTCGACGAAGCCCTCGAAGCCCTGGCCGGCGACGGTGTCCGGGTCCGGCGGGTCGCGGTGGACTACGCCTCCCACACCCGGCACGTCGAGGCGATCGCCGAAACCCTGGCCAAGACCTTGGCCGGGATCGACGCGCGGGTTCCGGCGATTCCGTTCTATTCCACCGTCCTGGGCACGTGGATCGAGCAGGCCGTCGTCGACGCGGGCTACTGGTACCGGAACCTGCGGCAGCAGGTGCGGTTCGGCCCCTCGGTGGCGGACCTGGCCGGGCTGGGGCACACGGTGTTCGTGGAGATCAGCGCCCACCCGGTGCTGGTCCAGCCGCTGAGCGAGATCAGCGACGACGCGGTGGTGACCGGGTCGCTGCGGCGGGACGACGGGGGACTGCGGCGCCTGCTGGCGTCGGCGGCCGAACTGTACGTCCGGGGCGTGGCCGTGGACTGGACGGCGGCCGTGCCCGCGGCCGGCTGGGTGGACCTGCCGACGTACGCCTTCGACCGCCGCCACTTCTGGCTGCACGAAGCCGAGACCGCCGAAGCCGCCGAGGGCATGGACGGCGAGTTCTGGACGGCGATCGAACAGTCCGATGTGGACAGCTTGGCCGAGCTGCTCGAGCTGGTGCCGGAGCAGCGCGGGGCGCTCAGCACCGTCGTGCCCGTGCTGGCGCAGTGGCGGGACCGGCGCCGCGAGCGCTCGACCGCGGAGAAGCTGCGCTACCAGGTCACCTGGCAGCCCCTGGAGCGCGAAGCCGCCGGCGTGCCGGGCGGGCGCTGGCTGGCCGTCGTCCCGGCCGGCACCACCGACGCGCTCCTGAAGGAGCTGACCGGCCAGGGACTCGACATCGTCCGGCTGGAGATCGAGGAAGCTTCGCGGGCACAGCTCGCCGAGCAGCTGCGGAACGTCCTGGCGGAGCACGACCTCACCGGCGTGCTGTCGCTGCTCGCTCTCGACGGCGGCCCCGCGGACGCGGCCGAGATCACCGCGTCGACGCTCGCGCTGGTCCAGGCCCTGGGCGACACCACCACGTCCGCGCCGCTGTGGTGCCTCACTTCCGGCGCGGTGAACATCGGCATCCAGGACGCCGTGACCGCACCGGCCCAGGCGGCCGTGTGGGGGCTCGGCCGGGCCGTCGCGCTGGAGCGCCTCGACCGGTGGGGCGGCCTGGTCGACTTGCCCGCCGCGATCGACGCCCGCACGGCTCAGGCCCTGCTCGGCGTCCTGAACGGCGCCGCCGGGGAAGACCAGCTCGCGGTCCGGCGCTCGGGCGTCTACCGCAGGCGGCTGGTCCGCAAGCCCGTGCCGGAGTCCGCGACGAGCCGGTGGGAACCCCGCGGCACGGTCCTGGTGACCGGTGGGGCCGAAGGACTCGGCCGGCACGCCTCGGTCTGGCTCGCGCAGTCCGGCGCCGAACGGCTCATCGTCACCGGCACCGACGGCGTCGACGAACTGACGGCCGAGCTGGCCGAGTTCGGCACCACGGTCGAGTTCTGCGCCGACACCGACCGGGACGCGATCGCGCAGCTGGTGGCGGACTCGGAGGTCACCGCCGTGGTGCACGCCGCGGACATCGCGCAGACCAGCTCCGTCGACGACACCGGCGTGGCCGACCTCGACGAGGTGTTCGCCGCGAAGGTGACCACCGCGGTGTGGCTGGACCAGCTGTTCGAGGACACCCCGCTCGACGCGTTCGTCGTGTTCTCCTCGATCGCCGGCATCTGGGGCGGTGGCGGGCAGGGCCCGGCGGGTGCGGCGAACGCCGTCCTCGACGCCCTGGTCGAATGGCGCCGGGCCCGCGGCCTCAAGGCGACGTCGATCGCCTGGGGCGCGCTCGACCAGATCGGCATCGGCATGGACGAGGCCGCCCTCGCCCAGCTGCGCCGCCGCGGTGTCATCCCGATGGCGCCGCCGCTGGCGGTCACCGCGATGGTGCAGGCGGTCGCCGGCAACGAGAAGGCCGTGGCGGTGGCCGACATGGACTGGGCCGCCTTCATCCCGGCGTTCACCTCGGTCCGGCCCAGCCCGCTGTTCGCCGATCTGCCCGAGGCGAAGGCCATCCTCCGGGCGGCGCAGGACGACGGCGAAGACGGCGACACCGCGTCGTCGCTCGCGGACTCCCTGCGCGCGGTCCCCGACGCCGAGCAGAACCGCATCCTGCTGAAGCTGGTCCGCGGCCACGCTTCGACGGTGCTCGGCCACAGCGGCGCCGAAGGCATCGGCCCGCGCCAGGCGTTCCAGGAGGTCGGCTTCGACTCGCTGGCCGCGGTCAACCTCCGCAACAGCCTGCACGCGGCCACCGGGCTGCGGCTGCCCGCGACGCTGATCTTCGACTACCCCACCCCGGAGGCGCTGGTCGGCTACCTGCGCGTCGAACTCCTGCGGGAGGCCGACGACGGCCTGGACGGGCGGGAAGACGACCTCCGGCGAGTCCTCGCGGCCGTGCCGTTCGCCCGGTTCAAGGAGGCGGGCGTGCTGGACACGCTGCTCGGCCTCGCCGACACCGGCACCGAACCGGGCACGGACGCCGAGACCACCGAAGCGGCCCCGGCCGCCGACGACGCAGAACTGATCGACGCACTGGACATCTCCGGTCTCGTGCAACGAGCCCTCGGGCAGACGAGCTGA	MRTDLIKPLHVALLENATRFAGKPAFADDHRTVTYGDLEARTRRLAGHLAGLGVRHGDRVAICLGNRVSTVESYFAILRAGAVGVPLNPGSATAELEHPLTDSGATVVVTDAAQAARLRLAPHVELLVTGDDVPEGAHSYDELALSEPAEPAADDLELDEPAWMFYTSGTTGRPKGVVSTQRNCLWSVASCYVPFPGLSDQDRVLWPLPLFHSLSHIACVLSATVVGASVRIADGSSADDVMRLIEAESSTFLAGVPTTYHHLVRAARQRGFSAPSLRIGLAGGAVLGAGLRSEFEETFGVPLIDAYGSTETCGAITMNPPDGARVEGSCGLAVPGVDVRVVDPDTGLDVPAGEEGEVWVSGPNVMLGYHNSPEATAAAMRDGWFRTGDLARRDDAGYFTICGRIKELIIRGGANIHPGEVEAVLRTVDGVADAAVGGVPHDTLGEVPVAYVIPGPTGFDPAALIEKCREQLSAYKVPDRILEVAHIPRTASGKIRRGLLTDEPAQLRYAATEHEEQSRHADESVAAALRARLSGLDERAQCELLEDLVRTQAADVLGQPVPDGRAFRDLGFTSLAIVELRNRLTEHTGLWLPASAVFDHPTPAALAARVRAELLGITQAVAEPVVAADPGEPIAIVGMACRLPGGVASPEDLWRLVAERVDAVSEFPGDRGWDLDSLIDPDRERAGTSYVGQGGFLHDAGEFDAGFFGISPREAVAMDPQQRLLLETSWEALENAGVDPIALKGTDTGVFSGLMGQGYGSGAVAPELEGFVTTGVASSVASGRVSYVLGLEGPAVTVDTACSSSLVAMHLAAQALRQGECSMALAGGVTVMATPGSFVEFSRQRALAPDGRCKAFAAAADGTGWSEGVGVVVLERLSVARERGHRILAVLRGSAVNQDGASNGLTAPNGLSQQRVIRRALAAAGLAPSDVDVVEAHGTGTTLGDPIEAQALLATYGQERKQPLWLGSLKSNIGHAQAAAGVAGVIKMVQALRHETLPPTLHVDKPTLEVDWSAGAIELLTEARAWPRNGRPRRAGVSSFGVSGTNAHLILEEAPAEEPVAAPELPVVPLVVSARSTESLSGQAERLASLLEGDVSLTEVAGALVSRRAVLDERAVVVAGSREEAVTGLRALNTAGSGTPGKVVWVFPGQGTQWAGMGRELLAESPVFAERIAECAAALAPWIDWSLVDVLRGEGDLGRVDVLQPACFAVMVGLAAVWESVGVRPDAVVGHSQGEIAAACVSGALSLEDAAKVVALRSQAIAAELSGRGGMASVALGEDDVVSRLVDGVEVAAVNGPSSVVIAGDAHALDATLEILSGEGIRVRRVAVDYASHTRHVEDIRDTLAETLAGISAQAPAVPFYSTVTSEWVRDAGVLDGGYWYRNLRNQVRFGAAATALLEQGHTVFVEVSAHPVTVQPLSELTGDAIGTLRREDGGLRRLLASMGELFVRGIDVDWTAMVPAAGWVDLPTYAFEHRHYWLEPAEPASAGDPLLGTVVSTPGSDRLTAVAQWSRRAQPWAVDGLVPNAALVEAAIRLGDLAGTPVVGELVVDAPVVLPRRGSREVQLIVGEPGEQRRRPIEVFSREADEPWTRHAHGTLAPAAAAVPEPAAAGDATDVTVAGLRDADRYGIHPALLDAAVRTVVGDDLLPSVWTGVSLLASGATAVTVTPTATGLRLTDPAGQPVLTVESVRGTPFVAEQGTTDALFRVDWPEIPLPTAETADFLPYEATSAEATLSALQAWLADPAETRLAVVTGDCTEPGAAAIWGLVRSAQSEHPGRIVLADLDDPAVLPAVVASGEPQVRVRNGVASVPRLTRVTPRQDARPLDPEGTVLITGGTGTLGALTARHLVTAHGVRHLVLVSRRGEAPELQEELTALGASVAIAACDVADRAQLEAVLRAIPAEHPLTAVIHTAGVLDDGVVTELTPDRLATVRRPKVDAARLLDELTREADLAAFVLFSSAAGVLGNPGQAGYAAANAELDALARQRNSLDLPAVSIAWGYWATVSGMTEHLGDADLRRNQRIGMSGLPADEGMALLDAAIATGGTLVAAKFDVAALRATAKAGGPVPPLLRGLAPLPRRAAAKTASLTERLAGLAETEQAAALLDLVRRHAAEVLGHSGAESVHSGRTFKDAGFDSLTAVELRNRLAAATGLTLSPAMIFDYPKPPALADHLRAKLFGSAANRPAEIGTAAAEEPIAIVAMACRFPGGVHSPEDLWRLVADGADAVTEFPADRGWDTDRLYHEDPDHEGTTYVRHGAFLDDAAGFDAAFFGISPNEALAMDPQQRLLLETSWELFERAAIDPTTLAGQDIGVFAGVNSHDYSMRMHRAAGVEGFRLTGGSASVLSGRVAYHFGVEGPAVTVDTACSSSLVALHMAVQALQRGECSMALAGGVMVMGTVETFVEFSRQRGLAPDGRCKAFADGADGTGWSEGVGLLLVERLSEAQRRGHQVLAVVRGSAVNSDGASNGLTAPNGPSQQRVIRKALAAAGLSTSDVDAVEAHGTGTTLGDPIEAEALLATYGQNRETPLWLGSVKSNLGHTQAAAGVAGVIKMVMAMRHGVLPRTLHVDRPSSYVDWSAGAVELLTEARDWVSNGHPRRAGVSSFGIGGTNAHVVLEEVAAPITTPQPEPAEFLVPVLVSARTAAGLRGQAGRLAAFLGDRTDVRVPDAAYALATTRAQLDHRAVVLASDRAQLCADLAAFGSGVVTGTPVDGKLAVLFTGQGSQWAGMGRELAETFPVFRDAFEAACEAVDTHLRERPLREVVFDDSALLDQTMYTQGALFAVETALFRLFESWGVRPGLLAGHSIGELAAAHVSGVLDLADAGELVAARGRLMQALPAGGAMVAVQATEDEVAPLLDGTVCVAAVNGPDSVVLSGTEAAVLAVADELAGRGRKTRRLAVSHAFHSPLMEPMLDDFRAVAERLTYRAGSLPVVSTLTGELAALDSPDYWVGQVRNAVRFSDAVTALGAQGASTFLELGPGGALAAMALGTLGGPEQSCVATLRKNGAEVPDVLTALAELHVRGVGVDWTTVLDEPATAVGTVLPTYAFQHQRFWVDVDETAAVSVTPPPAEPIVDRPVQDVLELVRESAAVVLGHRDAGSFDLDRSFKDHGFDSLSAVKLRNRLRDFTGVELPSTLIFDYPNPAVLADHLRAELLGERPAAPAPVTRDVSDEPIAIVGMSTRLPGGADSPEELWKLVAEGRDAVSGFPVDRGWDLDGLYHPDPAHAGTSYTRSGGFLHDAAQFDAGLFGISPREALAMDPQQRLLLETSWEALERAGVDPLSARGSDVGVFTGIVHHDYVTRLREVPEDVQGYTMTGTASSVASGRVAYVFGFEGPAVTVDTACSSSLVAMHLAAQALRQGECSMALAGGATVMASPDAFLEFSRQRGLSADGRCKAYAEGADGTGWAEGVGVVVLERLSVARERGHRVLAVLRGSAVNQDGASNGLTAPNGPSQQRVIRGALASAGLAPSDVDVVEGHGTGTALGDPIEVQALLATYGQEREQPLWLGSLKSNLGHTQAAAGVVGVIKMIMAMRHGVMPATLHVDERTSQVDWSAGAIEVLTEAREWPRTGRPRRAGVSSFGASGTNAHLIIEEGPAEEAVDEEVASVVPLVVSARSAGSLAGQAGRLAAVLENESLAGVAGALVSGRATLNERAVVIAGSRDEAQDGLQALARGENAPGVVTGTAGKPGKVVWVFPGQGSQWMGMGRDLLDSSPVFAARIKECAAALEQWTDWSLLDVLRGDADLLDRVDVVQPASFAMMVGLAAVWTSLGVTPDAVLGHSQGEIAAACVSGALSLDDAAKVVALRSQAIAGELAGRGGMASVALSEEDAVARLTPWANRVEVAAVNSPSSVVIAGDAQALDEALEALAGDGVRVRRVAVDYASHTRHVEAIAETLAKTLAGIDARVPAIPFYSTVLGTWIEQAVVDAGYWYRNLRQQVRFGPSVADLAGLGHTVFVEISAHPVLVQPLSEISDDAVVTGSLRRDDGGLRRLLASAAELYVRGVAVDWTAAVPAAGWVDLPTYAFDRRHFWLHEAETAEAAEGMDGEFWTAIEQSDVDSLAELLELVPEQRGALSTVVPVLAQWRDRRRERSTAEKLRYQVTWQPLEREAAGVPGGRWLAVVPAGTTDALLKELTGQGLDIVRLEIEEASRAQLAEQLRNVLAEHDLTGVLSLLALDGGPADAAEITASTLALVQALGDTTTSAPLWCLTSGAVNIGIQDAVTAPAQAAVWGLGRAVALERLDRWGGLVDLPAAIDARTAQALLGVLNGAAGEDQLAVRRSGVYRRRLVRKPVPESATSRWEPRGTVLVTGGAEGLGRHASVWLAQSGAERLIVTGTDGVDELTAELAEFGTTVEFCADTDRDAIAQLVADSEVTAVVHAADIAQTSSVDDTGVADLDEVFAAKVTTAVWLDQLFEDTPLDAFVVFSSIAGIWGGGGQGPAGAANAVLDALVEWRRARGLKATSIAWGALDQIGIGMDEAALAQLRRRGVIPMAPPLAVTAMVQAVAGNEKAVAVADMDWAAFIPAFTSVRPSPLFADLPEAKAILRAAQDDGEDGDTASSLADSLRAVPDAEQNRILLKLVRGHASTVLGHSGAEGIGPRQAFQEVGFDSLAAVNLRNSLHAATGLRLPATLIFDYPTPEALVGYLRVELLREADDGLDGREDDLRRVLAAVPFARFKEAGVLDTLLGLADTGTEPGTDAETTEAAPAADDAELIDALDISGLVQRALGQTS	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	851.62	gnl|BL_ORD_ID|4935|hsp_num:0	5928			138	1665	colistin A; colistin B
BGC0000136.1|Rifamycin_22 # 52535 # 57730 # 1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.739	BGC0000136.1|Rifamycin_22 	52535	57730	+	Loose	1000	29.6462	MCR-1.10	29.85	3004506	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	TTGAGTTCAGTGGCTGACGAGGGACAACTCCGCGACTACCTCAAGCGGGCCATCGCCGACGCCCGCGACGCCCGCACGCGGCTGCGCGAGGTCGAGGAGCAGGCGCGGGAGCCGATCGCCATCGTCGCCATGGCGTGCCGGTACCCGGGCGGGGTGTCCTCGCCCGAGGACCTGTGGCGGCTGGTGGCCGAGGGGACCGACGCCGTCTCCGCGTTCCCCGGCGACCGCGGCTGGGACGTCGACGGGCTCGTCGACCCGGACCCCGACCGCCCGGGCACGACGTACACGGACCAGGGTGGCTTCCTCCACGAGGCCGGCCTCTTCGACGCGGGGTTCTTCGGGATCTCGCCGCGGGAGGCCGTCGCGATGGACCCGCAGCAGCGGCTGCTGCTGGAGACGTCCTGGGAGGCCATCGAACGCACCGGCACCGACCCGCTTTCGCTGAAGGGCAGCGACATCGGCGTCTTCACCGGCGTCGCGAGCATGGGTTACGGCGCCGGTGGCGGCGTGGTCGCGCCGGAGCTGGAGGGTTTCGTCGGCACCGGTGCGGCGCCGTGCATCGCGTCCGGCCGGGTGTCGTACGTCCTCGGCTTCGAAGGCCCGGCGGTCACCGTCGACACCGGGTGTTCGTCGTCGCTGGTGGCGATGCACCTCGCCGCGCAGGCGCTGCGGCGGGGTGAGTGCTCGATGGCTCTGGCCGGCGGCGCGATGGTGATGGCCCAGCCGGGTTCGTTCGTGTCCTTCTCGCGGCAACGCGGGCTCGCCCTGGACGGGCGCTGCAAGGCGTTTTCGGACAGCGCCGACGGGATGGGACTGGCCGAGGGCGTCGGCGTCATCGCGCTGGAACGGCTGTCGGTCGCCCGTGAGCGTGGGCACCGGGTGCTGGCCGTGCTGCGCGGTATCGCGGTGAACCAGGATGGCGCGTCGAACGGCTTGACCGCCCCGAACGGCCCGTCCCAGCAGCGGGTGATCCGCGCCGCGCTGGCCGAAGCCGGGCTGTCGCCGTCCGATGTGGACGCCGTCGAAGGGCACGGGACGGGCACGACGCTGGGCGATCCGATCGAAGCGCAGGCGTTGCTGGCCACCTACGGCAAGGGCCGGGACCCGGAGAAGCCGCTCTGGCTGGGCTCGGTGAAGTCGAACCTCGGGCACACGCAAGCGGCCGCGGGCGTGGCCAGCGTGATCAAGATGGTGCAGGCGCTGCGCCACGGCGTGCTGCCCCCGACGCTGCACGTCGACCGGCCGTCCACCGAAGTCGACTGGTCGGCCGGTGCGGTCTCGCTGTTGACGGAGGCTCGGGAGTGGCCGCGCGAAGGGCGGCCGCGCCGGGCCGGGGTGTCCTCGTTCGGGATCAGCGGGACCAACGCGCACCTCATCCTGGAGGAAGCGCCCGAGGAGGAGCCGCCCGTCGCCGAAGCGCCTTCCGCCGGAGTGGTGCCCGTGGTGGTGTCGGCTCGTGGGGCCCTGGCGGGTCAGGCCGGCCGGCTGGCCGCGTTCCTCGAGGCGTCCGACGAGCCGTTGGTGACCGTCGCCGGGGCGCTGATCTGCGGCCGGTCCCGGTTCGGCGACCGGGCCGTCGTGGTGGCGGGCACGCGCGCAGAGGCGACGGCCGGGCTGGCCGCGCTGGCCCGCGGCGAAAGCGCCGCCGACGTCGTGACCGGCACGGTCGCGGCCTCGGGCGTGCCGGGCAAGCTCGTGTGGGTGTTCCCGGGCCAGGGTTCGCAGTGGGTGGGCATGGGCCGGGAGCTCCTCGAAGCCTCGCCGGTGTTCGCCGCGCGGATCGCGGAGTGCGCGGCTGCCCTCGAACCGTGGATCGACTGGTCGCTGCTGGACGTCCTCCGTGGCGAGGGCGACCTCGACCGCGTCGACGTGGTGCAGCCCGCGAGTTTCGCGGTGATGGTCGGCCTGGCCGCGGTGTGGTCGTCCGTCGGGGTGGTGCCCGACGCGGTGCTCGGGCACTCGCAGGGGGAGATCGCGGCGGCGTGCGTGTCGGGGGCGTTGTCGCTGCAGGACGCGGCGAAGGTGGTCGCGTTGCGCAGCCAGGCGATCGCGGCGAAGCTGGCCGGCCGCGGCGGCATGGCCTCGGTCGCGCTGAGCGAGGAAGACGCGGTCGCGCGGTTGCGGCACTGGGCGGACCGGGTCGAGGTGGCCGCGGTCAACAGCCCGTCGTCGGTGGTGATCGCCGGCGACGCCGAAGCCCTCGACCAGGCCCTCGAAGCACTGACCGGCCAGGACATCCGGGTCCGGCGGGTGGCGGTGGACTACGCCTCGCACACCCGGCACGTCGAAGACATCCAGGAGCCCCTCGCCGAGGCACTGGCCGGGATCGAGGCGCACGCGCCGACCCTGCCGTTCTTCTCGACCCTCACCGGTGACTGGATTCGCGAAGCGGGCGTCGTGGACGGCGGCTACTGGTACCGGAACCTGCGCAACCAGGTCGGTTTCGGCCCGGCGGTGGCCGAGCTGCTCGGCCTCGGCCACCGGGTGTTCGTCGAGGTCAGCGCGCACCCCGTGCTCGTCCAGGCGATCAGCGCGATTGCCGACGACACCGACGCGGTCGTCACCGGCTCGCTGCGGCGCGAGGAGGGCGGCCTGCGGCGGCTGCTGACGTCGATGGCCGAGCTGTTCGTCCGCGGAGTCGACGTGGACTGGGCCACGATGGTGCCGCCAGCGCGGGTCGATTTGCCGACCTACGCCTTCGACCACCAGCACTACTGGCTGCGGTACGTCGAGACCGCGACCGACGCGGCCGGTCCGGTGGTCCGGCTGCCGCAGACGGGCGGCCTGGTCTTCACCACCGAGTGGTCGCTGAAGTCACAGCCGTGGCTGGCCGAGCACACCCTGGAAGACCTGGTCGTCGTCCCCGGCGCGGCACTGGTCGAGCTGGCCGTCCGGGCCGGTGACGAGGCCGGGACCCCGGTGCTGGACGAACTCGTCATCGAGACGCCCCTGGTCGTGCCGGAACGCGGCGCGATCCGGGTGCAGGTCACGGTGAGCGGACCGGACGACGGCACACGGACCCTGGAAGTGCATTCCCAGCCCGAAGACGCCACCGACGAATGGACCCGGCACGCCACCGGCACGCTGTCGGCGACCCCGGACGAAAGCAGCGGGTTCGACTTCACGGCCTGGCCGCCCCCGGGCGCCCGGCAGCTCGACGGCGTTCCGGCGATCTGGCGGGCCGGCGACGAGATCTTCGCCGAAGTCTCCCTGCCCGACGATGCGGACGCCGAGGCATTCGGCATCCACCCCGCGCTCCTGGACGCGGCCCTGCACCCCGCCCTGCCCGGCGATGACGGTCTGACGCAGCCCATGGAATGGCGTGGCCTGACGCTGCACGCCGCGGGGGCGTCGACGCTGCGGGTCCGGTTGGTGCCCGGCGGGTTCCTGGAAGCGGCCGACGGCGCCGGCAGCCTGGTCGTCACGGCGAAGGAGGTTGCCCTCCGCCCGGTGACGATCGCGCGGTCGCGCACCACCACCCGAGACTCGCTGTTCCAGCTGAACTGGATCGAGCTGCCCGAGAGTGGCGTGGTGGCCGCGGCAGACGACACCGAGGTGCTGGAGGTGCCCGCGGGCGATTCCCCGCTGGCGGCGACCTCCCGAGTCTTGGAGCGGCTCCAGACCTGGCTGACCGAGCCCGAGGCGGAACAGCTGGTCGTCGTGACGCGCGGCGCGGTGCCCGCCGGGGACACCCCGGTGACCGACCCGGCCGCGGCGGCGGTCTGGGGCCTGGTCCGGTCCGCGCAGGCGGAGAACCCGGACCGGATCGTCCTGCTCGACACCGACGGCGAAGTCCCGCTGGGTGCGGTGCTGGCCGGCGGCGAGCCGCAGGTCGCGGTGCGCGGCACGGCGCTGTACGTCCCGCGCCTGGCCCGCGCCGACGCGGCCCCGGTATCCGGTCTACATGGGACGGTCCTCGTCTCCGGTGCCGGTGTGCTCGGCGAGATCGTGGCGCGGCACCTGGTCACCCGCCACGGCGTGCGCAAGCTGGTGCTCGCCAGCCGCCGCGGCCTGGACGCCGACGGCGCGAAGGACCTCGTCACCGACCTCACCGGCGAGGGCGCGGACGTGTCCGTCGTCGCCTGCGACCTGGCCGATCGGAACCAGGTGGCCGCGCTGCTGGCCGACCACCGCCCGGCGAGCGTCATCCACACGGCGGGCGTCCTCGACGACGGCGTCATCGGGACGCTGACCCCGGAGCGGCTGGCCAAGGTGTTCGCGCCCAAGGTCGACGCGGTCCGCCATCTCGACGAGCTGACTCGCGACCTCGACCTCGACGCGTTCGTCGTGTTCTCCTCCGGCTCCGGCGTGTTCGGTTCGCCGGGGCAGGGCAACTACGCGGCGGCGAACGCGTTCCTGGACGCGGCGATGGCGAGCCGCCGCGCGGCGGGTCTTCCTGGTCTCTCGCTGGCGTGGGGCCTGTGGGAACAGGCCACCGGCATGACCGCGCACCTCGGCGGCACCGACCAGGCCCGGATGAGCCGGGGCGGGGTGCGGCCGATCACGGCCGAGGAAGGCATGGCCCTGTTCGACACGGCACTGGGTGCGCAGCCCGCGCTGCTCGTGCCGGTCAAGCTCGACCTGCGGGAGGTGCGGGCCGGCGGGGCCGTGCCGCACCTGCTGCGCGGGCTGGTCCGGGCCGGGCGGCGGCAGGCCCAAGCCGCGTCCACAGTGGACAACCAGCTGCTGGGCCGGCTGGCCGGGCTGGGCGCGCCCGAGCAGGAGGCGCTGCTCGTCGACCTCGTGCGCGGCCAGGTCGCGGCGGTGCTCGGGCACGCCGGGCCGGACGCGGTCCGCGCCGACACGGCGTTCAAGGACGCCGGGTTCGACTCGCTCACCTCGGTCGACCTGCGCAACCGGCTGCGGGAGAGCACCGGGCTGAAGCTGCCCGCCACGCTCGCCTTCGACTACCCGACCCCGCTGGTCCTCGCCCGGCACCTGCGTGACGAGCTCGGGGCCGGCGACGACGCGCTTTCGGTGGTGCACGCGCGGCTCGAAGACGTCGAGGCGCTGCTCGGCGGGCTGCGCCTCGACGAATCCACGAAGACCGGTCTCACCCTCCGGCTGCAGGGCCTGGTCGCCCGGTGCAACGGCGTGAACGACCAGACCGGCGGCGAAACGCTGGCGGACCGGCTCGAGGCCGCGTCCGCCGACGAAGTCCTCGACTTCATCGACGAGGAGCTGGGTCTCACCTGA	MSSVADEGQLRDYLKRAIADARDARTRLREVEEQAREPIAIVAMACRYPGGVSSPEDLWRLVAEGTDAVSAFPGDRGWDVDGLVDPDPDRPGTTYTDQGGFLHEAGLFDAGFFGISPREAVAMDPQQRLLLETSWEAIERTGTDPLSLKGSDIGVFTGVASMGYGAGGGVVAPELEGFVGTGAAPCIASGRVSYVLGFEGPAVTVDTGCSSSLVAMHLAAQALRRGECSMALAGGAMVMAQPGSFVSFSRQRGLALDGRCKAFSDSADGMGLAEGVGVIALERLSVARERGHRVLAVLRGIAVNQDGASNGLTAPNGPSQQRVIRAALAEAGLSPSDVDAVEGHGTGTTLGDPIEAQALLATYGKGRDPEKPLWLGSVKSNLGHTQAAAGVASVIKMVQALRHGVLPPTLHVDRPSTEVDWSAGAVSLLTEAREWPREGRPRRAGVSSFGISGTNAHLILEEAPEEEPPVAEAPSAGVVPVVVSARGALAGQAGRLAAFLEASDEPLVTVAGALICGRSRFGDRAVVVAGTRAEATAGLAALARGESAADVVTGTVAASGVPGKLVWVFPGQGSQWVGMGRELLEASPVFAARIAECAAALEPWIDWSLLDVLRGEGDLDRVDVVQPASFAVMVGLAAVWSSVGVVPDAVLGHSQGEIAAACVSGALSLQDAAKVVALRSQAIAAKLAGRGGMASVALSEEDAVARLRHWADRVEVAAVNSPSSVVIAGDAEALDQALEALTGQDIRVRRVAVDYASHTRHVEDIQEPLAEALAGIEAHAPTLPFFSTLTGDWIREAGVVDGGYWYRNLRNQVGFGPAVAELLGLGHRVFVEVSAHPVLVQAISAIADDTDAVVTGSLRREEGGLRRLLTSMAELFVRGVDVDWATMVPPARVDLPTYAFDHQHYWLRYVETATDAAGPVVRLPQTGGLVFTTEWSLKSQPWLAEHTLEDLVVVPGAALVELAVRAGDEAGTPVLDELVIETPLVVPERGAIRVQVTVSGPDDGTRTLEVHSQPEDATDEWTRHATGTLSATPDESSGFDFTAWPPPGARQLDGVPAIWRAGDEIFAEVSLPDDADAEAFGIHPALLDAALHPALPGDDGLTQPMEWRGLTLHAAGASTLRVRLVPGGFLEAADGAGSLVVTAKEVALRPVTIARSRTTTRDSLFQLNWIELPESGVVAAADDTEVLEVPAGDSPLAATSRVLERLQTWLTEPEAEQLVVVTRGAVPAGDTPVTDPAAAAVWGLVRSAQAENPDRIVLLDTDGEVPLGAVLAGGEPQVAVRGTALYVPRLARADAAPVSGLHGTVLVSGAGVLGEIVARHLVTRHGVRKLVLASRRGLDADGAKDLVTDLTGEGADVSVVACDLADRNQVAALLADHRPASVIHTAGVLDDGVIGTLTPERLAKVFAPKVDAVRHLDELTRDLDLDAFVVFSSGSGVFGSPGQGNYAAANAFLDAAMASRRAAGLPGLSLAWGLWEQATGMTAHLGGTDQARMSRGGVRPITAEEGMALFDTALGAQPALLVPVKLDLREVRAGGAVPHLLRGLVRAGRRQAQAASTVDNQLLGRLAGLGAPEQEALLVDLVRGQVAAVLGHAGPDAVRADTAFKDAGFDSLTSVDLRNRLRESTGLKLPATLAFDYPTPLVLARHLRDELGAGDDALSVVHARLEDVEALLGGLRLDESTKTGLTLRLQGLVARCNGVNDQTGGETLADRLEAASADEVLDFIDEELGLT	MVQHTSVWYRCSVSPFVLVASVSVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLVRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDTRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNTICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFITQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	319.96	gnl|BL_ORD_ID|2669|hsp_num:0	3134			1188	1389	colistin A; colistin B
BGC0000136.1|Rifamycin_24 # 68022 # 68798 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.680	BGC0000136.1|Rifamycin_24 	68022	68798	+	Loose	550	24.6386	OXA-416	23.88	3001607	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTTCGACGTGGAGACCTACCTCCAGCGGATCGGCTGCGGCGGGGAAACCGGCGTGGACCTCGAAACGCTGGCGAAGCTGCAGAAGAGCCACCTGATGGCGATCCCGTACAGCAGCCTCGCCTACGAACTCCGGGACGCGGTGAACGTCGTCGACCTCGACGAGGACGACGTCTTCGTCACCAGCATCGCCGAAGGGCAGGGCGGCGCCTGCTACCACCTGAACCGGCTGTTCCACCGGCTCCTGACCGAACTCGGCTACGACGTCACGCCGCTGGCCGGCAGCACCGCCGAAGGCCGGGAGACCTTCGGCACCGACGTCGAGCACATGTTCAACCTGGTCACCCTGGACGGCGCCGACTGGCTCGTGGACGTCGGCTACCCCGGCCCCACCTACGTCGAGCCACTGGCGGTCTCGCCCGCGGTGCAGACCCAGTACGGGAGCCAGTTCCGGTTGGTGGAACAGGAAACCGGTTATGCGCTGCAACGCCGGGGTGCGGTCACCCGCTGGAGCGTCGTCTACACGTTCACGACGCAACCGCGTCAGTGGAGTGACTGGAAGGAACTGGAGGACAACTTCCGGGCCCTCGTGGGGGACACCACCCGCACCGACACGCAGGAAACCCTGTGCGGCCGCGCGTTCGCGAACGGCCAGGTCTTCCTGCGGCAGCGCCGCTACCTGACGGTCGAGAACGGCCGCGAGCAGGTGCGCACGATCACCGACGACGACGAGTTCCGGGCGCTGGTGTCCCGCGTGCTGTCCGGCGACCACGGCTGA	MFDVETYLQRIGCGGETGVDLETLAKLQKSHLMAIPYSSLAYELRDAVNVVDLDEDDVFVTSIAEGQGGACYHLNRLFHRLLTELGYDVTPLAGSTAEGRETFGTDVEHMFNLVTLDGADWLVDVGYPGPTYVEPLAVSPAVQTQYGSQFRLVEQETGYALQRRGAVTRWSVVYTFTTQPRQWSDWKELEDNFRALVGDTTRTDTQETLCGRAFANGQVFLRQRRYLTVENGREQVRTITDDDEFRALVSRVLSGDHG	MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDTFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP	97.36	gnl|BL_ORD_ID|2563|hsp_num:0	3499			174	735	cloxacillin; oxacillin; cefalotin
BGC0000136.1|Rifamycin_25 # 68818 # 69006 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.656	BGC0000136.1|Rifamycin_25 	68818	69006	+	Loose	650	22.7126	MexH	64.29	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGGAAAAAGCGGGCCTGCTGGCGAAGTTCGCCGGCCTCTGCAAAACCGCCTACGAGCACCACTACATCCCGTACCTGCACTTCTTCTACGGCGGCGAGTACCTCCACCACGGCAGCGAGCCGGTGTCCCGGATCGCGGACCTGCCGTACGTGACCGTGCCGGAGCCGCGGAAGAAGGCGCCGTGA	MTEKAGLLAKFAGLCKTAYEHHYIPYLHFFYGGEYLHHGSEPVSRIADLPYVTVPEPRKKAP	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	16.76	gnl|BL_ORD_ID|1350|hsp_num:0	1344			810	852	acriflavine; tetracycline; norfloxacin
BGC0000136.1|Rifamycin_26 # 69003 # 70058 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.752	BGC0000136.1|Rifamycin_26 	69003	70058	+	Loose	400	28.4906	AAC(3)-IVa	30.17	3002539	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAGGACGACGATCCCGGTCCGCCTGGCGGAACGGTCCTACGACGTGCTCGTCGGCCCCGGGGTGCGGGCGGCGCTGCCCGAGGTCGTCCGGCGGCTCGGCGCGAGACGGGCCGTGGTCGTGTCGGCCCGGCCGGCGGACTGGGTGCCCGGCACCGGCGTCGAGACCCTGCTGCTCCAGGCGCGCGACGGCGAGCCGACCAAGCGGCTGTCCACAGTGGAGGAACTGTGCGGTGAGTTCGCGCGGTTCGGGCTCACCCGGTCCGACGTCGTGGTCTCCTGCGGCGGCGGCACGACCACGGACGTCGTCGGGCTCGCGGCCGCGCTGTACCACCGGGGGGTCGCCGTGGTCCACCTGCCCACGTCCCTGCTCGCCCAGGTCGACGCCAGCGTCGGCGGGAAGACCGCGGTGAACCTGCCGGCGGGCGAGAACCTCGTCGGGGCGTACTGGCAGCCCAGCGCGGTGCTGTGCGACACGGACTACCTGACGACGCTGCCGCGGCGGGAGGTGCTGAACGGCCTCGGCGAGATCGCCCGCTGCCACTTCATCGGCGCGCCGGACCTGCGGGGGCGCTCGCGCCCGGAGCAGATCGCCGCCAGCGTCACCCTCAAGGCGGGCATCGTCGCGCAGGACGAGCGGGACACCGGCCCGCGGCACCTGCTCAACTACGGCCACACGCTGGGGCACGCGCTGGAGATCGCGACCGGCTTCGCCCTGCGCCACGGCGAGGCGGTGGCGATCGGCACGGTCTTCGCGGGCCGGCTGGCCGGCGCGCTCGGCCGCCTCGACCAGTCCGGTGTGGACGAACACCTCGCCGTCGTCCGCCACTACGGCCTGCCCGCCGCGCTGCCCGCGGACGTCGACCCGGCGGTGCTCGTCCGGCAGATGTACCGGGACAAGAAGGCGATCACCGGGCTCGCCTTCGTCCTGGCCGGGCCGCGGGGCGCGGAGCTGGTGAGCGACGTGCCGGCGCCGGTCGTCACCGACGTCCTGGACCGGATGCCCCGCGACAGCCTGGAAAACCTGGTGGGGACGACGGAAGCGGCGGCGCCGTGA	MRTTIPVRLAERSYDVLVGPGVRAALPEVVRRLGARRAVVVSARPADWVPGTGVETLLLQARDGEPTKRLSTVEELCGEFARFGLTRSDVVVSCGGGTTTDVVGLAAALYHRGVAVVHLPTSLLAQVDASVGGKTAVNLPAGENLVGAYWQPSAVLCDTDYLTTLPRREVLNGLGEIARCHFIGAPDLRGRSRPEQIAASVTLKAGIVAQDERDTGPRHLLNYGHTLGHALEIATGFALRHGEAVAIGTVFAGRLAGALGRLDQSGVDEHLAVVRHYGLPAALPADVDPAVLVRQMYRDKKAITGLAFVLAGPRGAELVSDVPAPVVTDVLDRMPRDSLENLVGTTEAAAP	MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVMPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG	136.05	gnl|BL_ORD_ID|4915|hsp_num:0	639			36	366	dibekacin; sisomicin; apramycin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000136.1|Rifamycin_27 # 70055 # 71380 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000136.1|Rifamycin_27 	70055	71380	+	Loose	710	26.5646	tet(35)	23.57	3000481	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAAGCGGCAGCCGGACTTCGCGGCCCACGGCCGGGCGGTCGACCGGGTGCTGGCCGGCCGGCTGAGCGCGGCGCTGGCCCGGCCGGCCGCGCAGCAGCCGGGCTGGCCGGACGCCGAGCGGGCGGCCGAGGTGATCGAGCTGCTGCACGACGCCGAGCCGATCGTGGCGCCGGAGGAGACCGCACGGTTGCGCGCCCGGCTCGCGTCGGTCGCCCGCGGCGAGGCGTTCCTGCTGCAGGGCGGGGACTGCGCGGAGACGTTCGCCGGCAACACCGAGCCGCACCTGCGGGCCAACCTCGGGGTGCTGGCGCGGATGGGCGAAGTGCTGGCCGAGGCGGCCGGCCTGCCGGTGGTCAAGATCGCCCGGATGGCCGGGCAGTTCGCCAAGCCGCGGTCCCGGACCGTCGACGCGCTGGGCCTGCCGGTGTACCGGGGCGACATCGTGAACTCCCCGGAGTGCACGGTCGCCGCCCGGACCCCCGACCCGCACCGGATGCTGCTGGCATACGCCCACGCCGCCGGCGCGATGGACCTCGTCCGCAAGCTCTGCGCCGAGGGCCTCGAAGAACCCCTGGCGGCGCAGGTGGTGCTCGCGGGCGCCCGCCGCGCGTCGTCGCCCGGCGGGCGGCCGTTCCCGGACTTCGGCCGGCCACCGCGCCCGGCCGAGATCTACGTCAGCCACGAAATGCTCCTGCTCGACTACGAGCGGGCCGTCCTGCGGACGGATTCCAGCGGGCCGGAACCGCGGCTGTCCAGCGGGCTGGCGCACTTCCTGTGGATCGGCGAGCGCCCCGCCAGCTCGACGGCGCCCACATCGACGTTCGCGGAGCTGCTGTCCAACCCGATCGGGCTGAAGCTGGGGCCGAGCTGCACCCCGGAGGAGGTCGTCGAGTACGTGCGGCGGCTCGACCCGCACCGCACGCCGGGCCGGCTGACGCTGGTCAGCCGGATGGGGCACGCCCAGGTCCGGGAGCTCCTCCCGCCGATCGTGGAGAAGGTCGCCGCCTCCGGGCACGAGGTGATCTGGCAGTGCGACCCGATGCACGGCAACACCCGGACCTCGGGCAACGGCTACAAGACCCGGCACTTCGGCCACGTCGTCGCCGAGCTGGCCGGCTTCTTCGCCGTGCACCGGCAGCTCGGCACCCATCCCGGCGGCATCCACGTCGAGGTGACCGGCGACGACGTGACGGAATGCCTCGGCGGGGCCGCGGGCATCGCGGAGGCCGACCTGCCCGACCGCTACCTGACCGCCTGCGATCCGCGGCTCAACGCCGACCAGTCGGTCGAACTCGCGTTCGCGATCGCGAAGATGCTGCGCTAG	MKRQPDFAAHGRAVDRVLAGRLSAALARPAAQQPGWPDAERAAEVIELLHDAEPIVAPEETARLRARLASVARGEAFLLQGGDCAETFAGNTEPHLRANLGVLARMGEVLAEAAGLPVVKIARMAGQFAKPRSRTVDALGLPVYRGDIVNSPECTVAARTPDPHRMLLAYAHAAGAMDLVRKLCAEGLEEPLAAQVVLAGARRASSPGGRPFPDFGRPPRPAEIYVSHEMLLLDYERAVLRTDSSGPEPRLSSGLAHFLWIGERPASSTAPTSTFAELLSNPIGLKLGPSCTPEEVVEYVRRLDPHRTPGRLTLVSRMGHAQVRELLPPIVEKVAASGHEVIWQCDPMHGNTRTSGNGYKTRHFGHVVAELAGFFAVHRQLGTHPGGIHVEVTGDDVTECLGGAAGIAEADLPDRYLTACDPRLNADQSVELAFAIAKMLR	MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFGLDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSKSKMASCQNA	119.51	gnl|BL_ORD_ID|1927|hsp_num:0	1969			537	942	tetracycline
BGC0000136.1|Rifamycin_28 # 71400 # 72191 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=5bp;gc_cont=0.747	BGC0000136.1|Rifamycin_28 	71400	72191	+	Loose	500	25.7942	OXA-361	36.84	3001548	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCGATCAGCGGCACCACCCGCCTGTACGTCGTGCTGGGCGACCCGGTCGCCCAGGTCCGGTCGCCCGGGCTGCTGAACCCGCTCTTCGCGGACCTGGACGTCGACGCGGTGCTCGTCCCGGTGCACGCGCCGCCGCCGCACCTCGAGCGGATCGTCGCCGGGCTGCAGGCCGTCGCCAACCTCGACGGCATCTTCGTCACCGTGCCGCACAAGGTGGCCGTGGCCGGGCTCGCCGACCGGCGCAGCCCGATGGTGGAGATCACCGGCAGCGCCAACGCCTTGCGGCGCGAAGCCGACGGCCGGTGGTACGCCGAGAACTTCGACGGCACCGGCTTCGTCGCCGGGCTGGTCGAGGCCGGGCACGACCCGAAGGCCCGGCGGGTGTCCCTCGTCGGCGCCGGTGGGGCGGGCAGCGCCATCGCGGCCGCCGTGCTGGCGGCCGGCGCCGACCGGCTGGCGCTGTGCGACCCGGACACCGCGAAGCTGGCCGCCCTCAAGGGCCGCCTGGACGTGCACTGGCCGGGCCGGACGTCGGTGTCGGCCGAGCCGGACACCGCGGGCGCCGACCTCGTCGTGAACGCGACCCCGCTCGGGCTGCGGCCCGGCGACCCGCTGCCGTTCCGGCCGGACCGGCTGGCGCCGGGCCGCGTGGTCGCCGACATCATCATGAAACCCCGCGAAACCCGCCTTCTCCGCGAAGCGGCGGCCCTCGGCCACGACGTCCATTACGGCAGCCACATGCTCGCCGGGCAATTGGACTCCTATCGCGATTTCTTCGGCCTGGGTTGA	MPISGTTRLYVVLGDPVAQVRSPGLLNPLFADLDVDAVLVPVHAPPPHLERIVAGLQAVANLDGIFVTVPHKVAVAGLADRRSPMVEITGSANALRREADGRWYAENFDGTGFVAGLVEAGHDPKARRVSLVGAGGAGSAIAAAVLAAGADRLALCDPDTAKLAALKGRLDVHWPGRTSVSAEPDTAGADLVVNATPLGLRPGDPLPFRPDRLAPGRVVADIIMKPRETRLLREAAALGHDVHYGSHMLAGQLDSYRDFFGLG	MKILILLPLFSCLGLTACSLPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKVMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVKTPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG	95.29	gnl|BL_ORD_ID|555|hsp_num:0	608			12	123	cloxacillin; oxacillin; cefalotin
BGC0000136.1|Rifamycin_31 # 74662 # 75360 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.721	BGC0000136.1|Rifamycin_31 	74662	75360	+	Loose	850	27.7202	abeM	43.75	3000753	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGACATTCCCGATCGTCGACCGGCCGGACACCGGGGCCGATCCCTCGGCACCGGTCCGGCACGCGGTCATCTTCGACCTCGACGGGGTCGTCGTCGACAGCTTCGCGGTGATGAGCGAGGCCTTCGCCATCGCCTACGCCGAGGTGGTCGGCGACGGGCCCGCGCCCTTCGAGGAGTATCGGCGCCACCTCGGTCGATACTTTCCGGATATCATGCGGATCATGGACCTTCCACTGGAGATGGAGGAACCCTTCGTCCGCGAGAGCTACCGCCTCGCCGGCGAAGTCCAGGTCTTCGACGGGGTCACCGAGCTGCTCCTGACGCTGCGGACGCGTGGCCTGCGGCTGGCCATCGCCACCGGCAAGAGCGGGCCGCGGGCCCGGTCCCTGCTCGACAACCTCGGCCTGCTCCCGTTCTTCGAGCACGTCATCGGCTCCGACGAGGTCGCCCGGCCCAAGCCGGCGCCCGACATCGTGCGCCACGCGCTGGACCTGCTGGACGTCCCGCCGGAGGCGGCCATCATGATCGGCGACGCCCCCACCGACCTGGCCAGCGCCCGAGGCGCCGGCGTCGCGTCGGCCGCCGCGCTGTGGGCGCCCCCGGACGACATCGGCGAGCTGCTCGCCGCCGGTCCCGACGTGGTGCTGCGACAGCCGGCCGACCTGCTCGCGCTCTGTCCGTCGGTGCCCGGCCGCTGA	MTFPIVDRPDTGADPSAPVRHAVIFDLDGVVVDSFAVMSEAFAIAYAEVVGDGPAPFEEYRRHLGRYFPDIMRIMDLPLEMEEPFVRESYRLAGEVQVFDGVTELLLTLRTRGLRLAIATGKSGPRARSLLDNLGLLPFFEHVIGSDEVARPKPAPDIVRHALDLLDVPPEAAIMIGDAPTDLASARGAGVASAAALWAPPDDIGELLAAGPDVVLRQPADLLALCPSVPGR	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	51.79	gnl|BL_ORD_ID|1254|hsp_num:0	1368			324	414	ciprofloxacin; acriflavine; norfloxacin; ofloxacin; triclosan
BGC0000136.1|Rifamycin_32 # 75365 # 76276 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000136.1|Rifamycin_32 	75365	76276	+	Loose	400	27.335	vanR gene in vanC cluster	28.07	3002922	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGGGCACCCCGTACCACCTCGGCATCGACGTGGGAGGCACGAAAGTCGCCTTCCGCGTCGAGTCCGGCTCCGCCTGTATCGAGGAAACCTCGTTCAGCTGGGGAGCCCGGCACAGTGCCGAGGACGACCTCGCCCAGCTGGCCGGCCACGTGGCCCGGCTGCGGGAGCGCATCGGCACGCCGCTGGAGGCGGTCGGGGTCGCCATGCCCGGCACCGTCGGCGCGGACGGCCGGGTCGCGACCTGGCCCAGCCGCCCGGAGTGGACCGGGGTGGACCTGAAAACGGCGTTGCACTCGCTGTTCCCCGAAGCGGCGGTCGCCTGGGCGGACGACGGCGATCTCGGCGCGCTCGCCGAGTCCCGGGCGTCGGGCTGCGAGAACCTGCTGTACATCGGGATCGGCACCGGCATCGGCGGCGGCCTGGTCCTGGGTGGCGTGCCGTGCCCCGGCCTCGGCCGCGGTTCGTTCGAGATCGGCCACGTGATCGTGGAGATGGGCGGCGTCCGCTGTGTGTGCGGCCGCCGCGGCTGCCTGCAGGCACTCGCCTCCGGCCCGGCGACCCTCCGCCGCGCGAGCCTGTTGCGCGGAGCGGACGTCACCTACTACCGGCTGCAGCGGGCGCTGCGCAACGGAGAGCCGTGGGCGGCCGACGCGCTGGAAGGAAGCACCCGGGCGCTGGCGGCCGCGGTGACCGGCGTCCAGGAGCTGGTCCACCCGGACCGCGTGCTGATCGGCGGCGGGTTCGCGGCGGGGATCCCGGAGATCGTGCCGTCGGTGTCGGGGTTCCTGGCGGATCTGGTGCGACAGGGTCAGGCGCCGCTGCCGGTGGAACCGGCCGCGTTGGGCGGGCTGTCGTCGTTGCGGGGAGCGGTGGCCCTCGCCGGGCTGGTGGCGGCGGGGGAAGTGCCGTGA	MGTPYHLGIDVGGTKVAFRVESGSACIEETSFSWGARHSAEDDLAQLAGHVARLRERIGTPLEAVGVAMPGTVGADGRVATWPSRPEWTGVDLKTALHSLFPEAAVAWADDGDLGALAESRASGCENLLYIGIGTGIGGGLVLGGVPCPGLGRGSFEIGHVIVEMGGVRCVCGRRGCLQALASGPATLRRASLLRGADVTYYRLQRALRNGEPWAADALEGSTRALAAAVTGVQELVHPDRVLIGGGFAAGIPEIVPSVSGFLADLVRQGQAPLPVEPAALGGLSSLRGAVALAGLVAAGEVP	MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDIDGFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSETLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK	131.17	gnl|BL_ORD_ID|1500|hsp_num:0	1547			456	627	vancomycin
BGC0000136.1|Rifamycin_33 # 76343 # 77110 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.710	BGC0000136.1|Rifamycin_33 	76343	77110	+	Loose	500	26.1794	APH(6)-Id	32.5	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGGGCACTCTCGTTTCCTTCCACGCACACCCCAACGACGACACCACCACCTGCGGAGGCGTCCTGCGCAAGGCCCACGAGGACGGCCACCGCGTCGTCCTCGTGCTCGCCACCCGCGGCGAACTCGGCTACAACCCGGACGGTCTCCTCGCCGAGGGCGAGACCTTGGGCGACCGACGGGCCGTCGAAGCCCGGGCGGCCGCCGACGTGCTCGGGGTGGACCGGCTCGAGTTCCTCGGCTACACCGATTCCGGGATGACGGCCGCGGCCGACGGCGCCGGCACGTTCCAGACCGCCGACGTCGAGGAAGCGGCGCGGAAGCTCGCCGCGATCCTGCGCGAGGAGCGGGCGGACGTGCTGACGGTGTACGACGAGAAGGGCACCTACGGCGACCCCGACCACATCCAGGTGCACCGCGTCGGCACGCGGGCCGCGGAACTGGCGGGCACGGCGAAGGTCTTCCAGTCCACGATCAACCGCGAGCACATCAAGGCGAACCAGCGCGTGCTCGCCGAGCAGGCCGGCGTCGACCTGCCCGCGGGCCCGGACTTCGGCACCCCGGAGGCCGAGCTCACCTGCCGCGTCGACGTCTCCGCGTACACCGAGTACAAGCGCAAGGCGCTGCTCGCCCACGCCAGCCAGATCACCCCGCAGTCCACGCTGTTCACGGACCTGCCGGAGGACACGTTCCGCACCATGTTCGGCACCGAGTGGTTCATCCGCGCCGGTCAGGGGCCGGGCATCACCGAAACCGACCTGATGGCGTAA	MGTLVSFHAHPNDDTTTCGGVLRKAHEDGHRVVLVLATRGELGYNPDGLLAEGETLGDRRAVEARAAADVLGVDRLEFLGYTDSGMTAAADGAGTFQTADVEEAARKLAAILREERADVLTVYDEKGTYGDPDHIQVHRVGTRAAELAGTAKVFQSTINREHIKANQRVLAEQAGVDLPAGPDFGTPEAELTCRVDVSAYTEYKRKALLAHASQITPQSTLFTDLPEDTFRTMFGTEWFIRAGQGPGITETDLMA	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	91.73	gnl|BL_ORD_ID|950|hsp_num:0	1031			468	588	streptomycin
BGC0000136.1|Rifamycin_35 # 78407 # 79984 # 1 # ID=1_35;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.708	BGC0000136.1|Rifamycin_35 	78407	79984	+	Loose	600	233.032	Acinetobacter baumannii AmvA	34.54	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCGCGAAATGCACGCCACGGCGGCGGTGACCGAAACCCGGAATCCACGGCGCTGGCTGATTCTGGCCGTCATCTCGCTGGCCCAGCTGGTCGTCCTGGTCGACAACACGGTTTTGAACCTGGCCATCCCCAAGCTCACCGAAGATCTCGGCGCCACCACCGCCGATATCCAATGGATGATCAACGCCTACGCCCTCGTCCAATCCGGGCTGCTTTTGACGGCCGGCAGTTTCAGTGACCGGTACGGCCGGAAACGGTCGTTGCTCGCCGGGCTCCTGCTGTTCGGCGTGGGTTCGCTGGCCGCGGCGTTCAGCCTGTCGTCCGGGCAGCTGATCGCCGCGCGGGCCGGGATGGGCATCGGCGGTGCGCTGCTGACCACCACCACGCTGGCCGTCGTCATGCAGGTCTTCGACGAAAAAGAACTGCCGAAGGCGATCGGGCTGTGGAGCGCGGTCAGCTCCTTCGGCTACGCCAGCGGCCCGCTGATCGGCGGCGCGCTGCTCGCGCACTTCTGGTGGGGCTCGATCTTCCTCATCAACATCCCGGTGGCGCTGCTCGGCTGCGTCGCCGTGGCGAAACTCGTGCCGGAATCCAAGGACCCGCAAGGCGCCCGGCCCGATCTGGTCGGTGCCGCGCTCTCCACGATCGGCATGGCCGGGATCGTCTACGCGATCATCTCCGGCCCGGAGCACGGCTGGGCCTCGGCCACCGTCCTGGTGGCGGCCGGCATCGGCGTGGCCGCGCTGGCCGCGTTCGTCCGGTGGGAGCTGCACGTGCCGCACCCCATGCTCGACATGGGTTTATTCCGCAACCGCCGGTTCAACGGCGCGATCTCCGGCGGCCTGCTGGTCGCCTTCGGGATGGGCGGCTCGGTCTTCCTGCTGACGCAGCAACTGCAGCTCGTGCTCGGCTACGACCCCCTGGAGGCCGGGCTCCGGACGGCTCCGCTCGCGCTGGTGGTCGTCGCGCTGAACGTCGCCGGGCTCGGCGCGAAGCTGCTCGAGAAGCTGGGCATCGCCATGACGATCGCCGTCGGGATGACGCTGAACGCCGTCGGGCTCGCCATGGTGGCCGTGCTGGGCACGCCCGATCGCGGGTTCGGCGGAATGCTGGCCTGCCTGCTCGTCATGGGTGGCGGTATCGCGCCGGCCATGCCCGCCATGGCCAACGCCATCATGACCTCGATCCCGGCCGAGAAGGCGGGGGCGGGAGCCGCGGTGCAGGGCACCGTGAACCAGTTCGGCAGCGGGCTCGGCGTCGCCATCCTCGGCGCCGTGCTCAACTCGCGGTTCGCCGCGCTGCTGCCGATCGGCCTCGGTGCCGGCGCCGCCGGTTCGCTGCACGAAGCGCTGCTCCAGGCGCGGACCCCCGCACTGCAGGCGCAGGTGCGCGACGCCTTCGCCGGCGGCGTGCGCGCCAGCGAGCTGATCGGGGCGCTGGCCGTGGTCCTCGGCGGCATGCTCGCCGGCATGCTGCTGCGCCGGGCGGCCCGGTCGGAGGCGCACCAGGCGGCCTGGGCCCGCCCCACGATCAGGCTGGAAGCGGCCCCTGCCCCCTTTACCGTTGACCTCCGGTGA	MREMHATAAVTETRNPRRWLILAVISLAQLVVLVDNTVLNLAIPKLTEDLGATTADIQWMINAYALVQSGLLLTAGSFSDRYGRKRSLLAGLLLFGVGSLAAAFSLSSGQLIAARAGMGIGGALLTTTTLAVVMQVFDEKELPKAIGLWSAVSSFGYASGPLIGGALLAHFWWGSIFLINIPVALLGCVAVAKLVPESKDPQGARPDLVGAALSTIGMAGIVYAIISGPEHGWASATVLVAAGIGVAALAAFVRWELHVPHPMLDMGLFRNRRFNGAISGGLLVAFGMGGSVFLLTQQLQLVLGYDPLEAGLRTAPLALVVVALNVAGLGAKLLEKLGIAMTIAVGMTLNAVGLAMVAVLGTPDRGFGGMLACLLVMGGGIAPAMPAMANAIMTSIPAEKAGAGAAVQGTVNQFGSGLGVAILGAVLNSRFAALLPIGLGAGAAGSLHEALLQARTPALQAQVRDAFAGGVRASELIGALAVVLGGMLAGMLLRRAARSEAHQAAWARPTIRLEAAPAPFTVDLR	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	106.71	gnl|BL_ORD_ID|2718|hsp_num:0	3280			6	1317	erythromycin; acriflavine
BGC0000136.1|Rifamycin_36 # 80000 # 80728 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.708	BGC0000136.1|Rifamycin_36 	80000	80728	+	Loose	400	50.447	tetR	30.43	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCAAACGGGCCTCGCAGCCCCGCGAGAGCGTGTGGCTTTCCCCGCGGCCGGCCCGCAAGCACCGGGCCGGCGAATCCGAGCTCGACCGCGAAAAGATCGTCGCCACCGCGGTCCGCGTCCTCGACGCCGAGGGCGACGCGAAGTTCTCGATGCGGCTGCTGGCCGAGGAACTCAACGTGACCCCGATGTCGGTGTACTGGTACGTCGCGAACAAGGACGACCTGCTCGAGCTGGCCCTCGATGCGGTGGCCGGCGAGATCGAGCTCCCGTCGCTCGACGACGGCAACGACTGGCGCGAGGACCTGCGCGCGCTCGCCCGCGCGTGGCGCCGCACGATGGTGGCCCACCCGTGGGCGATCCGCTGCTACGGCGAGTACCTGAACATCGGCCCGAGCAGCCTCCGCTTCACCGAGTGCGCCCAGGCGGTGATGGCGTGCTCACCGTTGCCGCTGAAGGACCGCTCGGCGGCGCTGAACGTGGTCTTCCAGTACGTCTACGGCTTCACGGCGACGGAGAGCCGCTGGCTGGAGCACCTCGCCGAAACGGGCCGCACGGCGGAGGAGTTCGCCGCCGAGGTGACGGGCAGCATGGCGGCGATGTCCTCGACGCTGGAGCAGGGCGGCCTGCTGGAGCGGGACGGCGACCAGTCGATGGAGCAGCTGCGGGACCGGGACTTCGACCGCGGGCTGAACTGGCTGTTCACCGGCATGGTCGCCGGCGGGTGA	MGKRASQPRESVWLSPRPARKHRAGESELDREKIVATAVRVLDAEGDAKFSMRLLAEELNVTPMSVYWYVANKDDLLELALDAVAGEIELPSLDDGNDWREDLRALARAWRRTMVAHPWAIRCYGEYLNIGPSSLRFTECAQAVMACSPLPLKDRSAALNVVFQYVYGFTATESRWLEHLAETGRTAEEFAAEVTGSMAAMSSTLEQGGLLERDGDQSMEQLRDRDFDRGLNWLFTGMVAGG	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	116.35	gnl|BL_ORD_ID|442|hsp_num:0	276			6	282	tetracycline
BGC0000136.1|Rifamycin_37 # 80735 # 81235 # -1 # ID=1_37;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.687	BGC0000136.1|Rifamycin_37 	80735	81235	-	Loose	150	33.8834	nimJ	25.64	3007112	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGGACCTGAGCATGACCGAGAAGGAAGAGCAGGAGTTCCTGGCCGGCAAGCACATCGGCGTGCTGGCGGTGCACCGGCGAAGCGGCCCGCCGCTGGCGGTACCGATGTGGTACGGCTACTCCCCCGGCGGCGACGTGCTGTTGTGGACCGACGGCGAGGACACCTTGAAGGGCAGGCTGATCAAGAAGAACGGCGCCTTCACCTTGGTGGTCCAGAACGAGGATCCGCCCTACCGGTACGTTTCCGTGTCGGGTCCGGTGACGGCGTGGGAAGAAGCCACCGTCGAGGCCGCGTATTCGGTGGCGTCGCGGTACCTGCCAGAGCGGCAGGCGCGGGAGTTCGTCGAGGCGTTCAACGCGGGCCACGTGATCATCCGGATGACGCCGGACCGCTGGCGCAGCGTCGACTACGGCAAGACGTCGAACGTCCTCACCGACCGCGAAGGGACCCGGCTGCGGGAACACGTGCAGACGGCCCGGCGCGGGCGCGGGCGCGACTGA	MDLSMTEKEEQEFLAGKHIGVLAVHRRSGPPLAVPMWYGYSPGGDVLLWTDGEDTLKGRLIKKNGAFTLVVQNEDPPYRYVSVSGPVTAWEEATVEAAYSVASRYLPERQAREFVEAFNAGHVIIRMTPDRWRSVDYGKTSNVLTDREGTRLREHVQTARRGRGRD	MNEFREMRRKRQQLSEEESIAILQKATAGTLALLGDNDYPYAVPISYVYADGRLYFHSALSGHKVDAIRKCDKASFCVIEQDEVHPEKYTTFFRSVIAFGRIHIIEDETEKLETARMLVNRYNPNQEEALQKELENGLSRMLMIRFDIEHLTGKEAIELVRRHQK	100.61	gnl|BL_ORD_ID|4789|hsp_num:0	5785			36	381	metronidazole
BGC0000136.1|Rifamycin_38 # 81320 # 82531 # -1 # ID=1_38;partial=00;start_type=TTG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.690	BGC0000136.1|Rifamycin_38 	81320	82531	-	Loose	600	25.7942	vanJ	31.67	3002914	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanJ membrane protein	TTGACGGAGACCGTCGCCTTCCCGCAAGACCGCACCTGCCCGTACCAGCCGGCGCCGGGTTACGAACCGCTCGCCGACCGGCGCCCGATCGCCGAGGTCACCCTCTACGACGGCCGCAAGGCCTGGGCGGTCACCGGGCACGAACTGGCCCGCAAGCTGCTGTGCGACCCGCGCATCTCCAGTGACCGGACCAATCCCGCGTGGCCGATGGTCAGCGCGGCCGCGGCCGTCGAGTTCACCGACGTCCAGCAGAAGGTCATCAAGCTGCTCACCGCGCTGGTGGGCGTCGACGGCCCGGCCCACCGGGCGCGGCGCAAGCTGGTGCAGGCGGGGTTCACGGTCAAGCGGATCGACTCCCTGCGGCCGAAGATCCAGGCGCTCGTCGACCGGCAGATCGACGAGATGATCGCCGAAGGCGCTCCGGTGGACCTGCTCAAGAAGTTCGCTTCGCCGGTGCCCCTGATCGCGTTGTGCGATCTGCTCGGCATCCCGCACGAGGACCAGGACTACTTCGAGAAGAAGGCGCACCAGATCCTGTTCGGGCCGGACGCCGGCGGGGCCTACGACGAGCTGATGGCCTACCTGACGAAGCTGATCGACAAGGCCGAGCAGAACCCGGGCGAAGAGGGGTTCCTGCAGGCCCTGCTCGCCGAGCGCGACCCGTCGAGCGACGTGGACCACGAGGAAATCCTGCAGATGTTCCTCATCGTGCTGGTGACCGGGCACGACACGACGTCGAGCTCGATCGGGCTCGGTGCCTTCACGCTGCTGCAGCACCCGGAACGGCTGGCCGAGCTGCGGGCGGACCCGTCGCTGATGCCCGCCGCGGTGGACGAGCTGACCCGGTTCGTGGTCGTCCCCGACGGCCTGCAGCGGGTGGCCGCGGACGACATCGAGGTCGACGCGGACACCACCATCCGCAAGGGCGACGGTGTGTTCTTCCTGTTCTCGCTCATCAACCGGGACGAGGAAGCCTACGAGGACGGCGACCGGCTGGATTGGCACCGCCCGACGTTCCGCGACCACCTGACCTACGGGTTCGGGACGCACCAGTGCGCGGGGATGAACCACGCGCGCGCCATCATGGAAATCGCTTTCCGGCGGCTGATCGACCGGCTGCCGGGATTGCGCCTGGCGGTCCCGGCCGACGAAGTCCGGGTCAAGCCGGGGGACGCGTTCCAAGGACTGGCCGAGCTGCCCGTCACTTGGTAG	MTETVAFPQDRTCPYQPAPGYEPLADRRPIAEVTLYDGRKAWAVTGHELARKLLCDPRISSDRTNPAWPMVSAAAAVEFTDVQQKVIKLLTALVGVDGPAHRARRKLVQAGFTVKRIDSLRPKIQALVDRQIDEMIAEGAPVDLLKKFASPVPLIALCDLLGIPHEDQDYFEKKAHQILFGPDAGGAYDELMAYLTKLIDKAEQNPGEEGFLQALLAERDPSSDVDHEEILQMFLIVLVTGHDTTSSSIGLGAFTLLQHPERLAELRADPSLMPAAVDELTRFVVVPDGLQRVAADDIEVDADTTIRKGDGVFFLFSLINRDEEAYEDGDRLDWHRPTFRDHLTYGFGTHQCAGMNHARAIMEIAFRRLIDRLPGLRLAVPADEVRVKPGDAFQGLAELPVTW	MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSVGSLVETFLPWFGLFVPVLAAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTARDLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDYGPLADTKPADVTMAGNRALRTTVATERGPLVVYVAHLGSVRLNPRAGFWTDSRDRNAWALGEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQILVRGVEPTGSWTLPATGSDHLPVAAGVSW	122.12	gnl|BL_ORD_ID|2036|hsp_num:0	2240			495	672	teicoplanin
BGC0000136.1|Rifamycin_39 # 82562 # 83827 # -1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.712	BGC0000136.1|Rifamycin_39 	82562	83827	-	Loose	400	25.409	vanR gene in vanP cluster	36.36	3007191	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGACCACCACTGCCGAGACTTCGGCCGAACCGGTCGACCTGTTCTCCCCGGAAGTGGTCGCCGACCCGTGGGGAGCGCACGCGGCGGTCCGCGAGGCGCCGACGCTGCAGATCGGCGGCTTCATGGGCGGGCCGCCGATGTACCTGGCCGCCCGCTACGAAGACGTCCGCCAGGTCCTGATGGACCAGCGGTTCCAGTGCAACCCGCTGGCCGATTCCCCCGCCGAGGACATCCGCAACGGCGTCTTCCGGCACCTGGACATGCCGGAGGAGCTGATCCCCTGGCTGAAGAACCTCATCAACGCCTCCGACGGCGAGGAGCACGCCCGGCTGCGCAAGCTGGTCTCCTACGCGCTCACCGCGCACCGGGTCGGCAAGTTCCGCCCCCGGGTCGAAGAGCTCACCGCGGAGCTGCTCGACAAGCTGGAAGCGGCGGGCGGTGACGGCACGCCGATCGACCTCGTCGAGTCGTTCTGCTACCCGCTGCCGGTCACCGTGATCTGCGAGCTGGTCGGCGTCGACCACGAAGACCGGCCGCAGTGGCGTGCGTGGAGCGACGCGATGGCCACCCTGGACGGCAAGCGGCTCCCGGAAGAAGTGCGCAAGACCCTCGCCGCCGCCCGCGGGATGATCGAGCGGCGCCGCGCCGAGCCGAAGGACGACATGGTCACCGCGCTCGTCGAGGCGCAGGCCAAGAACCCCGGCATCGCCACCGACGACGAGCTGGTCGGCGTCCTGTTCAGCCTGGTCACCGCCGGGCACCAGACGACCACCTACCTGATCGGCAACTCGGTGCTGGCCCTGCACGAGCACCCCGACCAGCTCGCGCGGCTCAAGGCCGACCCGTCGCTGTGGCCGCAGGCCGTGCGCGAACTGCAGCGCCTGGGCCCGATCCAGTTCGGGCAGCCGCGGTTCGCCACCGAGGACATCGAGGTGGGCGGCACGGTGATCCCGCGCGGCATGCCCGTGGTGCCGCTGATCATGGCCGCCAACAGCGACCCGCGGAAGTTCCCCGAGCCGGAGAAGCTGCAGATCGACCGGCTCGCCGTCGGCAGCGAGAGCCACCTCGGCTTCGGCAAGGGCATCCACCGCTGCCTCGGCCAGCACGTCGCCTACCTGGAGGCGGAAGTGGCCCTGCGCGGCCTGTACACCCGGTTCCCGGACATGACGCTGGCGGTGCCGCGCGAAGAGATCCCGTGGATCCTGCGGCCCGGCTTCACCCGGACCAAGGACCTCCCGGTGCGGCTCGCCCGGCCGGCGTCCTGA	MTTTAETSAEPVDLFSPEVVADPWGAHAAVREAPTLQIGGFMGGPPMYLAARYEDVRQVLMDQRFQCNPLADSPAEDIRNGVFRHLDMPEELIPWLKNLINASDGEEHARLRKLVSYALTAHRVGKFRPRVEELTAELLDKLEAAGGDGTPIDLVESFCYPLPVTVICELVGVDHEDRPQWRAWSDAMATLDGKRLPEEVRKTLAAARGMIERRRAEPKDDMVTALVEAQAKNPGIATDDELVGVLFSLVTAGHQTTTYLIGNSVLALHEHPDQLARLKADPSLWPQAVRELQRLGPIQFGQPRFATEDIEVGGTVIPRGMPVVPLIMAANSDPRKFPEPEKLQIDRLAVGSESHLGFGKGIHRCLGQHVAYLEAEVALRGLYTRFPDMTLAVPREEIPWILRPGFTRTKDLPVRLARPAS	MNNSQKNILIVDDEEEIADLLEVYLKNEGYQVFKYYSGQGVLECIEHEDIHLALLDVMLPDTDGFSLCRKIREKWFFPIIMLTAKVEETDKIMGITLGADDYITKPFNPLEVLARVKGQLRRADVYNVSLGNEEEASKENVFQIRGLEINENNHTCFLYGEEISLTPIEFNILLCLCKHLGEVVSSEELFETVWGEKYMDSNNTVFSHVARIREKMHEEARKPKFIKTVWGVGYKIEKS	176.15	gnl|BL_ORD_ID|4821|hsp_num:0	5807			15	147	vancomycin; teicoplanin
BGC0000136.1|Rifamycin_40 # 83901 # 85208 # -1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.683	BGC0000136.1|Rifamycin_40 	83901	85208	-	Loose	500	31.9574	OXA-364	24.05	3001551	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGTCGACTCAGCCCGATCGGACCTGCTGACGCAGGTTCGCGACTACCACGACGCCCAGTCCCCCGGGCCGGCGCCGTTCATCCCGGGGCAGACACCGATCCTGTCGTCCGGGGCGGTGCTGGACGCCGCCGACCGCGAAGCCCTGGTGGCCGCCGCGCTCGACCTGCGCATCGCCTCCGGCACCATCGCGACGAAGTTCGAGTCGTCCTTCGCCCGGAAACTCAAGCGGCGCAAGGCGGTGCTGACGAACTCCGGCTCGTCGGCGAACCTGCTGGCGCTGAGCACGCTGACGTCCCCGACGCTGGGCGACGAGCAGCTCAAGCCGGGCGACGAGGTCGTCACGGTCGCGGCCGGCTTCCCGACCACGGTGAACCCGATCCTGCAGAACGGCATGATCCCGGTGTTCGTCGACATCGAGCTCGGCACGTACAACACGACCGCCGAACGGGTCGAAGCGGCGATCTCCCCGCGCACGCGCGCCATCATGATCGCCCACACGCTGGGAAATCCTTTCCCGGTGGCGGAAATCGCCGAAATCGCCCAGCGCCACGGCTGCCACCTCATCGAGGACAACTGCGACGCCGTCGGCTCCACCTACCAGGGACAGCTCACCGGCACGTTCGGCCGGTTCTCGACGGTGTCCTTCTACCCAGCCCACCACCTGACCATGGGCGAGGGCGGCATGCTGCTGTCCTCGGACATCAAGCTGGCCAAGCTGGCGAAGTCGTTCCGCGACTGGGGCCGCGACTGCTGGTGCGAGCCCGGCGAGGACGACCGCTGCCTGAAGCGGTTCGACCTGCACCTCGGCACGCTGCCGGAGGCCTACGACCACAAGTACGTCTTCTCCGAGGTCGGCTACAACCTCAAGAGCACCGACATCCACGCCGCGCTCGGGCTGAGCCAGCTGGCGAAACTGCCGGACTTCGTCGACGCCCGCAAGCGCAACTGGCGTCAGCTGCGCGAAGGCCTCGACGGCCTGCCCGGGCTGATCCTGCCGGAGGCCACGCCGGGCAGCGACCCGAGCTGGTTCGGGTTCATCATCACGGTGAAACCCGACGCCGGCTTCGACGTCCCGGAGGTCGTCGAGTACCTCGAGGCGCGCAACATCCGCACCCGGCGGCTGTTCGCGGGCAACCTGACCCGCCACCCCGCCTACATCGGCAAGCCGCAGCGCATCGCCGGCCCGCTGACCAACAGCGACATCGTCACCGAGCGGACGTTCTGGATCGGCGTCTACCCGGGGATCACCACGGAGATGATCGAGTACGTGATCGGCACGCTCAAGGAGTTCGTCGCCACGCACTGA	MVDSARSDLLTQVRDYHDAQSPGPAPFIPGQTPILSSGAVLDAADREALVAAALDLRIASGTIATKFESSFARKLKRRKAVLTNSGSSANLLALSTLTSPTLGDEQLKPGDEVVTVAAGFPTTVNPILQNGMIPVFVDIELGTYNTTAERVEAAISPRTRAIMIAHTLGNPFPVAEIAEIAQRHGCHLIEDNCDAVGSTYQGQLTGTFGRFSTVSFYPAHHLTMGEGGMLLSSDIKLAKLAKSFRDWGRDCWCEPGEDDRCLKRFDLHLGTLPEAYDHKYVFSEVGYNLKSTDIHAALGLSQLAKLPDFVDARKRNWRQLREGLDGLPGLILPEATPGSDPSWFGFIITVKPDAGFDVPEVVEYLEARNIRTRRLFAGNLTRHPAYIGKPQRIAGPLTNSDIVTERTFWIGVYPGITTEMIEYVIGTLKEFVATH	MPLRLPLRALGAALSLFALAGAPASAAVLCTVVADAADGRIVFQQGTQAACAERYTPASTFKLPIALMGADAGILQGAHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATRPNAGLRARDELLREWPAMADAPRQ	158.18	gnl|BL_ORD_ID|2084|hsp_num:0	3481			87	324	cloxacillin; oxacillin; cefalotin
BGC0000136.1|Rifamycin_41 # 85339 # 86556 # 1 # ID=1_41;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.706	BGC0000136.1|Rifamycin_41 	85339	86556	+	Loose	700	49.2914	oleD	25.91	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	TTGGTGATGGCCCCGGGCTTCTCCGTGGGCAAGCTGGAGCCGACCACGAGCCACCCCTGGGAGGACGATCTTGTGAAGGTTCTAAATCTCGCCGGGGTCGCCCCGTCGACGGTGTTCAGCCACGTCCCGCTCGCGAACGCCCTGCGCAACGCCGGGCACCAGGTGATGACCACGGCGTCGGTCGACGAGATGGTCGACACGATCGCCGGCGTCGGGCTGTCCGCGGTGCGGACCACGGCGCCGGGCGTCACCCCGCGGCAGGTCATCGCCGAAAGCGGCCTGACGCACGTGCCGGAAGACCCGGCAGAGCGCGAAGTCATGGCCGGCCGCTGGTACGCGCACATGGAGTACGTGACCCTGGACGCCTTGCTGGCGTTCAGCAAGGACTGGCGCCCGGACGTCATCGTCAGCGGCGTCACCTCCTACTCCGGCCCGCTGCTGGCCGCCCACCTCGGCGTGCCGTACGTGCGCCACGCCTGGGACATCCACACCCCGCGGCTGATGGATCAGGGTGCCGAGGACCAGCTGCGCGAGCAGCTGACGGAACTCGGCCTGGACGGCCTGCCCGAGCCCGCCATGACGATCGAGATCGCGCCGCCGAGCCTGCTGCCGGACGACCTCAAGGGCGGCCAGCCGATGCGGTGGATCCCCGGCAACTCGCAGTCGGTGCTGGAACCGTGGATGTACACCAAGAGCGCGGGCACCCGGATCGGCGTCACCATCGGCACCGGGGTCGCGAACTACAACCAGTACGACTTCCTGCAGGCCGTCGTCGAACAGGTCGCCACCCTGGACGCCGAAGTCGTCGTGGCCGTCACCGAAGACGCGGCGCCGGAACTGCGTGAGCGGCTGAAGAACGTGCGGGCGGGCTGGATCCCGCTGGACGTCGTCGCGCCGACCTGTGACGTCCTGGTGCACCAGACCGGCGGCAGCACGATGATGACGGGCCTGAGCTTCGGCGTGCCGCAGGTGCTGCTCCCGGACCCCAACCTCTTCCGCGCCAACGCGATGGCCCGCCGGCTCGCCGACACCGGCGCCGCGGTCGTGCTCTCGCCCGAGGAAGCCACGAGCGAGGTCATCGCGAAGACGTGCGGCGAGCTGGTCGCCGACCCGGCGTTCAAGGCGGCCGCGGGCGGGCTCGCCCGGGAGATCGCCGAGCTGCCCTCGCCGAACGAAGTGGCGCTGCGCATCGAGCAGCTCGTCCGGGAAGCGTCCTAA	MVMAPGFSVGKLEPTTSHPWEDDLVKVLNLAGVAPSTVFSHVPLANALRNAGHQVMTTASVDEMVDTIAGVGLSAVRTTAPGVTPRQVIAESGLTHVPEDPAEREVMAGRWYAHMEYVTLDALLAFSKDWRPDVIVSGVTSYSGPLLAAHLGVPYVRHAWDIHTPRLMDQGAEDQLREQLTELGLDGLPEPAMTIEIAPPSLLPDDLKGGQPMRWIPGNSQSVLEPWMYTKSAGTRIGVTIGTGVANYNQYDFLQAVVEQVATLDAEVVVAVTEDAAPELRERLKNVRAGWIPLDVVAPTCDVLVHQTGGSTMMTGLSFGVPQVLLPDPNLFRANAMARRLADTGAAVVLSPEEATSEVIAKTCGELVADPAFKAAAGGLAREIAELPSPNEVALRIEQLVREAS	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	97.59	gnl|BL_ORD_ID|1253|hsp_num:0	1367			312	1209	erythromycin; tylosin
BGC0000136.1|Rifamycin_42 # 86563 # 87207 # 1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000136.1|Rifamycin_42 	86563	87207	+	Loose	500	27.7202	OXA-307	31.48	3001762	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGTAGCGTCAGCACCCGCAGCATGACCGTTCAGCCGCTGGCCATCGACGGCGCACACGTGGTCACGTCCCAGTCGTTCGGCGACGAGCGCGGCGACTTCTTCGAGGTCTACCGCCAGGACGTGCTCACCGAGGCGCTCGGCTACCGGCCGCGGTTCCTGCAAACGAACGTCTCGACGTCGTGCCGCAACGTCGTGCGCGGCGTGCACGGGGCGATGACCCCGCCCGGCCTGGCGAAGTTCGTGACGTGCCTGCGCGGTTCGCTGCTCGACTTCGTCGTCGACGTGCGGACCGGTTCCCCGACGTTCGGCCAGTGGGACATGATCGTGCTCAACCAGCACGGCGGGACCGCGGTGTACGTCGAGGAAGGCCTCGGCCACGCGTTCGTGTCCCTCGAAGACGACACGTGCGTCCAGTACCTGCTGTCCGACCTCTACCGGCCGGCGGAGGTGCTCACCGTGCAGCCGCTGGACCCGGAAATCGGCCTCCCGCTGAACCTGCCGGGCGAGCCGATCCTGTCCGAGCGCGACGCGGCGGCGCCGACGTTGCGGGAGGCCGGCGAGCTGGGCCTGCTGCCGCGGTACGAGGAGTGCCTCGCGCTGCGGGAGGCGCGCGTGCGGCTCGAAGTGTCCGTGGCTTCCTGA	MGSVSTRSMTVQPLAIDGAHVVTSQSFGDERGDFFEVYRQDVLTEALGYRPRFLQTNVSTSCRNVVRGVHGAMTPPGLAKFVTCLRGSLLDFVVDVRTGSPTFGQWDMIVLNQHGGTAVYVEEGLGHAFVSLEDDTCVQYLLSDLYRPAEVLTVQPLDPEIGLPLNLPGEPILSERDAAAPTLREAGELGLLPRYEECLALREARVRLEVSVAS	MSKKLKCLALLTPLILILPLTACQSPSQKKQQVVSLQNEQQRVANLFQQAQTTGVLVIYDGKQIQTYGNATRRADQRFIPASTFKILNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDLSLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKHIGTQVDNFWLVGPLKITPVEEVRFVYALAKQKLPFDQSTQQQVKDMLLVDEHQGTKIYAKSGWGMDVTPQVGWWTGWIEQPNGKIIAFSLNMQMSQPAHADARKVIVYQALQELGLLAN	76.98	gnl|BL_ORD_ID|3756|hsp_num:0	4826			522	669	cloxacillin; oxacillin; cefalotin
BGC0000136.1|Rifamycin_43 # 87270 # 88019 # -1 # ID=1_43;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000136.1|Rifamycin_43 	87270	88019	-	Loose	580	26.1794	ARL-2	24.21	3004735	protein homolog model	n/a	n/a	penam	antibiotic inactivation	ARL Beta-lactamase	GACGCCTGCCGGGTCGAGTGCGTGCGCGCGGTGCGCGACGCGATCGTCGCGGCCGGCCCGGAGAGCGTCGCCGCGGTGCTGATGGAGCCGGTCAACGGCACGACCGGCGGCGGGTACGTCCCGCCGGCGGGCTACCTGCGGGCGCTGCGCGAGGTCTGCGACGAGTTCGGCGTCCTCGTCATCCACGACGAGGTCCTCACCGGGCTGGGCCGCTGCGGGCTCCCGCTGGCCTCGCACCACACGCCGGGTTCGGCGGCGGACATCGTCACGCTGTCGAAGGGCCTCGGCGCGGGGTACGTCCCGCTGGCGGCCACGATGCTCTCGCCGGACCTGGCCGAGGACATCATGACCAGCGGCAAGTGGCTGCCGCTGATGGGCACGATGTCGGCGACCCCGCTGCAGGGCCGGGCCGGGCTGGCGGTGCTTTCGGTGCTGGAGGAGCTCGGCGCCCTCGACCGCGACGAAGTCCGCGGCGCGGCCCTCGGCCGGCTCGTGGCCGACGCCGTGCGCGGCCGGCAGGTGGTGACGGACGTCCGCGGGCTCGGGTACTTCTACGGCATCGAGCTGGCTCCCGGCACGCTCGGCGACGTCATGCGGATCACCCGGAGCCGGGGCCTGCTGCTGTACCCGTACGTCGGCTTCCGCCCCGACCGCACGGGCGAGGGCCTGCTGGTGGCCCCCCGCTCAACGCGACCGACGGCGATCTCGGCTTCCTCGGCGAGACGCTGGGCGCGGCACTGGACCAGCTGA	DACRVECVRAVRDAIVAAGPESVAAVLMEPVNGTTGGGYVPPAGYLRALREVCDEFGVLVIHDEVLTGLGRCGLPLASHHTPGSAADIVTLSKGLGAGYVPLAATMLSPDLAEDIMTSGKWLPLMGTMSATPLQGRAGLAVLSVLEELGALDRDEVRGAALGRLVADAVRGRQVVTDVRGLGYFYGIELAPGTLGDVMRITRSRGLLLYPYVGFRPDRTGEGLLVAPRSTRPTAISASSARRWARHWTS	MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFAYASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQSDNTASNIIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHSLQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVALIYPKHQTKPIVLVVFTKHQQQDAQPQDELVAQAARHAIHQLD	88.30	gnl|BL_ORD_ID|2403|hsp_num:0	3550			216	465	
